<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30050403</article-id>
<article-id pub-id-type="pmc">6050401</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2018.00467</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Axon-Myelin Unit in Development and Degenerative Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Stassart</surname>
<given-names>Ruth M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/566858/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Möbius</surname>
<given-names>Wiebke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/396597/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nave</surname>
<given-names>Klaus-Armin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/5493/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Edgar</surname>
<given-names>Julia M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/318503/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Neuropathology, University Medical Center Leipzig</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow</institution>, <addr-line>Glasgow</addr-line>, <country>United Kingdom</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Robert W. Burgess, Jackson Laboratory, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: John Svaren, University of Wisconsin-Madison, United States; Andrea Loreto, University of Cambridge, United Kingdom</p>
</fn>
<corresp id="c001">*Correspondence: Klaus-Armin Nave <email>nave@em.mpg.de</email></corresp>
<corresp id="c002">Julia M. Edgar <email>edgar@em.mpg.de</email>; <email>julia.edgar@glasgow.ac.uk</email></corresp>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>12</volume>
<elocation-id>467</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Stassart, Möbius, Nave and Edgar.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Stassart, Möbius, Nave and Edgar</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Axons are electrically excitable, cable-like neuronal processes that relay information between neurons within the nervous system and between neurons and peripheral target tissues. In the central and peripheral nervous systems, most axons over a critical diameter are enwrapped by myelin, which reduces internodal membrane capacitance and facilitates rapid conduction of electrical impulses. The spirally wrapped myelin sheath, which is an evolutionary specialisation of vertebrates, is produced by oligodendrocytes and Schwann cells; in most mammals myelination occurs during postnatal development and after axons have established connection with their targets. Myelin covers the vast majority of the axonal surface, influencing the axon's physical shape, the localisation of molecules on its membrane and the composition of the extracellular fluid (in the periaxonal space) that immerses it. Moreover, myelinating cells play a fundamental role in axonal support, at least in part by providing metabolic substrates to the underlying axon to fuel its energy requirements. The unique architecture of the myelinated axon, which is crucial to its function as a conduit over long distances, renders it particularly susceptible to injury and confers specific survival and maintenance requirements. In this review we will describe the normal morphology, ultrastructure and function of myelinated axons, and discuss how these change following disease, injury or experimental perturbation, with a particular focus on the role the myelinating cell plays in shaping and supporting the axon.</p>
</abstract>
<kwd-group>
<kwd>oligodendrocyte</kwd>
<kwd>Schwann cell</kwd>
<kwd>cytoskeleton</kwd>
<kwd>axonal transport</kwd>
<kwd>energy</kwd>
<kwd>neuroinflammation</kwd>
<kwd>morphology</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Multiple Sclerosis Society<named-content content-type="fundref-id">13039/501100000381</named-content></funding-source>
<award-id rid="cn001">038</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Horizon 2020<named-content content-type="fundref-id">10.13039/501100007601</named-content></funding-source>
<award-id rid="cn002">734584</award-id>
</award-group>
<award-group>
<funding-source id="cn003">European Research Council<named-content content-type="fundref-id">10.13039/501100000781</named-content></funding-source>
<award-id rid="cn003">MyeliNANO</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="238"></ref-count>
<page-count count="22"></page-count>
<word-count count="18475"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Neurons are highly polarized cells, with a long axon and shorter dendrites. Axons, which are the focus of this review, are unique among cellular processes, being capable of transmitting electrical impulses (spiking) and occupying, in many cases, an inordinately disproportionate amount of the neuron's volume. The axon's electrical excitability stems from the fact that <bold>axolemma</bold> (bolded terms are defined in Table <xref ref-type="table" rid="T1">1</xref>) is rich in voltage-gated ion channels and ion pumps (Dumenieu et al., <xref ref-type="bibr" rid="B43">2017</xref>). Extrapolation to humans, of serially reconstructed EM data from the highly branched basal cholinergic neurons of the forebrain in mice, suggests that single neurons can have a total axon length of 100 m (Wu et al., <xref ref-type="bibr" rid="B225">2014</xref>). This extraordinary cellular asymmetry is initiated during early development when neuronal polarisation is established (Schelski and Bradke, <xref ref-type="bibr" rid="B175">2017</xref>). All subsequent growth and maintenance of the axon is enabled by bidirectional axonal transport comprising molecular motors and microtubule tracks that convey materials between the cell body and the axon terminus. In electron micrographs, axons are easily distinguished from other cellular processes because of their unique cytoskeletal organization and, often, because they are surrounded by a myelin sheath (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Definitions.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Axolemma</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>The axon's plasma membrane</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Axoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top">The axon's cytoplasm</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Compact myelin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Concentric layers around the axon of double-layered oligodendroglial or Schwann cell plasma membrane, closely apposed at both intracellular and extracellular surfaces. See Figures <xref ref-type="fig" rid="F1">1A,B</xref>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">g-ratio</td>
<td align="left" colspan="1" rowspan="1" valign="top">A measure of myelin sheath thickness, defined as the ratio of the diameter of the fiber (axon plus myelin) to the diameter of the axon alone, which is always smaller than 1. It is calculated by measuring the circumference of each on nerve cross-sections, and converting areas to diameters, assuming the circumferences are circular.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Internode</td>
<td align="left" colspan="1" rowspan="1" valign="top">Refers to the myelinated segment of the axon; adjacent internodes are separated by a node of Ranvier. Figure <xref ref-type="fig" rid="F1">1D</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Juxtaparanode</td>
<td align="left" colspan="1" rowspan="1" valign="top">The internodal region closest to the paranode, which harbors fast voltage-gated potassium channels. Figure <xref ref-type="fig" rid="F1">1D</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Node of Ranvier</td>
<td align="left" colspan="1" rowspan="1" valign="top">Short non-myelinated axonal region that serves the generation of action potentials; morphologically a gap flanked by myelinated “internodes.” Nodes are usually ~1 μm in length and rich in voltage gated sodium channels. Figure <xref ref-type="fig" rid="F1">1D</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Non-compact myelin</td>
<td align="left" colspan="1" rowspan="1" valign="top">The part of the myelinating cell process where membranes do not compact. Consists largely of tubing around the periphery of the process as well as transient openings of previously compacted myelin in some CNS fibers, and Schmidt-Lanterman incisures in the PNS. See Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>. Also referred to as “myelinic channels.”</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Paranode</td>
<td align="left" colspan="1" rowspan="1" valign="top">The regions at either end of the internode where the non-compacted, paranodal loops of the myelin sheath about the axon Figure <xref ref-type="fig" rid="F1">1D</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Septate junction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intercellular junctions found in invertebrate epithelial cells that appear ladder-like by electron microscopy.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Spheroid</td>
<td align="left" colspan="1" rowspan="1" valign="top">An abnormal focal swelling of the axon; mainly observed in the CNS. Often the axonal cytoskeletal elements are disorganized and axonal organelles are enriched, as observed by electron microscopy. Spheroids can also be visualized by light microscopy using respective antigen markers such as amyloid precursor protein (APP), when its transport along the axon is impaired.</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Ultrastructure of myelinated axons in the CNS and PNS. (<bold>A</bold>, upper) In the CNS, myelinated axons are densely packed within white matter (here: mouse optic nerve) and the myelin sheaths of neighboring fibers often directly touch. At high magnification axonal cytoskeletal elements are visible: microtubules (arrows) and neurofilaments (arrowheads). As indicated in the schematic, mitochondria are closely associated with microtubules (M, mitochondria; IT, inner tongue; OT, outer tongue). (<bold>A</bold>, lower) In the PNS, the Schwann cell plasma membrane is covered with a basal lamina and the myelinated fibers are separated by connective tissue. Small caliber axons are not myelinated, but organized in so-called Remak bundles (R) formed by non-myelinating Schwann cells. At high magnification, mitochondria and cytoskeletal elements can be observed. <bold>(B)</bold> Schematic representation of a myelinated CNS fiber: The plasma membrane of the myelinating glial cell is depicted in green. The major dense line (depicted in grey) results from the apposition of the cytoplasmic surfaces of the plasma membrane. <bold>(C)</bold> Electron micrograph of a PNS node of Ranvier and (<bold>D</bold>, upper) schematic representation of the elements of a node: paranodal loops of the myelin sheath (green), Nav1.6 channels (red), Kv1 channels (blue), neurofilaments (arrowheads), microtubules (open arrowheads), mitochondria (M), which are transported along microtubules. N, node; PN, paranode; JPN, juxta paranode; IN, internode. (<bold>D</bold>, lower) Schematic representation of non-myelinated axon with uniform distribution of Nav1.6 channels along the axolemma.</p>
</caption>
<graphic xlink:href="fnins-12-00467-g0001"></graphic>
</fig>
</sec>
<sec id="s2">
<title>Organisation and morphology of myelinated fibres</title>
<sec>
<title>The ultrastructure of the myelinated axon</title>
<p>Recent advances in imaging modalities and in image processing have contributed enormously to our understanding of the three-dimensional composition of fibre tracts. For example, electron microscopic volume imaging, including electron tomography of fine ultrastructural details; focussed ion beam-scanning electron microscopy (FIB-SEM); and serial block-face imaging (SBF) of larger volumes, provide an increasingly complete picture of the axon-myelin unit and its neighbouring cells [see for example, Snaidero et al. (<xref ref-type="bibr" rid="B184">2014</xref>)].</p>
<p>This is not to detract from the fact that conventional transmission electron microscopy (EM) has been instrumental in elucidating the relationship between the axon and its myelin sheath as well as the subcellular components of each, in normal versus pathological or experimental conditions (reviewed in Boullerne, <xref ref-type="bibr" rid="B19">2016</xref>). Nonetheless, EM requires expertise and caution in tissue preparation and image interpretation. Conventional processing of tissue samples involving chemical fixation in aqueous solution, dehydration and plastic embedding, can generate considerable artefacts; mitochondria and the lipid-rich <bold>compact myelin</bold> being particularly susceptible to inadequate fixation. Consequently, “changes” in either must be interpreted in relation to control material handled in parallel. Cryopreparation, combining high-pressure-freezing and freeze-substitution (HPF-FS), has become a commonplace alternative (Möbius et al., <xref ref-type="bibr" rid="B119">2016</xref>) and whilst less easily obtained, cryopreparations generate useful reference samples for myelin and axon phenotypes that might otherwise be masked by artefacts of conventional preparation, in particular those caused by tissue shrinkage associated with dehydration.</p>
<p>Electron microscopy combined with state-of-the-art fluorescence super resolution imaging have illuminated ultrastructural details of the axonal cytoskeleton. In the adult, the axonal cytoskeleton comprises actin filaments, microtubules with microtubule associated proteins, and neurofilaments. Briefly, actin filaments, which have been observed recently in axons using fluorescence super-resolution imaging, are arranged as bundles along the axon and as periodically spaced rings underneath the axolemma, likely providing elasticity and stability, respectively (reviewed by Kevenaar and Hoogenraad, <xref ref-type="bibr" rid="B90">2015</xref>; Papandreou and Leterrier, <xref ref-type="bibr" rid="B139">2018</xref>). Neurofilaments and microtubules are about 100 μm long in mature axons. They are aligned with the axon's long axis and can be distinguished in electron micrographs of its cross section, being 90–100 and 230–260 Å in diameter, respectively (Peters and Vaughn, <xref ref-type="bibr" rid="B148">1967</xref>; Figure <xref ref-type="fig" rid="F1">1</xref>). Neurofilament heavy, medium and light chain triplets, in combination with α-internexin in the CNS or peripherin in the PNS, fashion a semi-rigid structure, providing temporary docking sites for vesicular organelles and integrating the membrane cytoskeleton and transmembrane adhesion molecules with the axon's interior (reviewed in Kirkcaldie and Dwyer, <xref ref-type="bibr" rid="B92">2017</xref>; Yuan et al., <xref ref-type="bibr" rid="B232">2017</xref>). Microtubules, which are uniformly orientated with the plus-end distally (reviewed in Rao and Baas, <xref ref-type="bibr" rid="B156">2018</xref>), act as scaffolds for axonal transport (Kapitein and Hoogenraad, <xref ref-type="bibr" rid="B86">2011</xref>; see Axonal transport). Cross-bridging proteins, such as spectrin, bullous pemphigoid antigen, plectin and microtubule associated proteins link neurofilaments, microtubules and actin (reviewed in Yuan et al., <xref ref-type="bibr" rid="B232">2017</xref>). At the <bold>node of Ranvier</bold> microtubules are more abundant and neurofilaments less highly phosphorylated and more closely spaced compared to the <bold>internode</bold>, consistent with a nodal narrowing of the axon's diameter (Figure <xref ref-type="fig" rid="F1">1</xref>) that is particularly pronounced in the PNS (Reles and Friede, <xref ref-type="bibr" rid="B160">1991</xref>).</p>
<p>The <bold>axoplasm</bold> also contains membrane-bound organelles; mitochondria being the most obvious in electron micrographs of the healthy axon. They are typically 0.1–0.3 μm in diameter, up to 10 μm in length, and oriented parallel to the axon's long-axis. In contrast to the PNS, they are not enriched at the <bold>node of Ranvier</bold> or <bold>paranode</bold> in CNS axons (Edgar et al., <xref ref-type="bibr" rid="B47">2008</xref>) where they occupy a constant fraction (1.5%) of the volume of axons &gt;0.7 μm diameter (Perge et al., <xref ref-type="bibr" rid="B142">2009</xref>), suggesting energy requirements are linearly related to axonal size. Axons also contain synaptic vesicle precursors and dense core vesicles, autophagosomes, signalling endosomes, late endosomes and lysosomes, amyloid precursor protein, BDNF vesicles, smooth endoplasmic reticulum and the machinery for localised protein synthesis (reviewed in Maday et al., <xref ref-type="bibr" rid="B112">2014</xref>; Lopez-Leal et al., <xref ref-type="bibr" rid="B106">2016</xref>; Spaulding and Burgess, <xref ref-type="bibr" rid="B188">2017</xref>; Wu et al., <xref ref-type="bibr" rid="B226">2017</xref>), which usually only become apparent following injury and regeneration (Lampert, <xref ref-type="bibr" rid="B101">1967</xref>; Tsukita and Ishikawa, <xref ref-type="bibr" rid="B206">1980</xref>; Court et al., <xref ref-type="bibr" rid="B33">2011</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Axonal organelle accumulations after traumatic injury or interruption of axonal transport. <bold>(A)</bold> Early description of axonal pathology after traumatic spinal cord injury in the rat, based on electron microscopic observations. (1) After transection the axonal stump swells and accumulates mitochondria, vesicles and dense bodies. (2) In a degenerative stage the organelles disintegrate. (3) A regenerative axon is characterized by a growth cone with multiple organelles. (4) A dystrophic axonal enlargement, caused by demyelinating disease or vitamin E deficiency is characterized by abundant filaments and organelles such as mitochondria, dense bodies, layered membrane loops, and cytoplasmic dense material. Reproduced from Lampert (<xref ref-type="bibr" rid="B101">1967</xref>), with permission. <bold>(B)</bold> Electron micrographs of focal swellings and organelle accumulations in CNS axons (upper: cross section, lower: longitudinal section), here derived from white matter of adult <italic>Plp1</italic> null mice. Note that organelle accumulations are predominantly located in the juxtaparanodal region (lower). <bold>(C)</bold> Electron micrographs of axonal changes in the PNS after interruption of axonal transport in the mouse saphenous nerve by cooling. At the distal side of the transport block, retrogradely transported axonal elements accumulate along the internode. These are, among others, multivesicular bodies (Mv), lamellated bodies (Lb) which intermingle with microtubules (T), and neurofilaments (Upper: cross section, Lower: longitudinal section). Reproduced from Tsukita and Ishikawa (<xref ref-type="bibr" rid="B206">1980</xref>) with permission.</p>
</caption>
<graphic xlink:href="fnins-12-00467-g0002"></graphic>
</fig>
<p>The myelin sheath comprises concentric wraps of the myelinating cell process around the axon, such that the lateral edges of the outermost layer abut the straddling <bold>nodes of Ranvier</bold>, and successively inner layers terminate increasingly distally from the node (depicted in Figures <xref ref-type="fig" rid="F1">1C,D</xref>). In <bold>compact myelin</bold>, an ~2 nm space (the intraperiod space) exists between the extracellular surfaces of the wrapping glial cell process whilst its intracellular surfaces are effectively fused (forming the major dense line). Together, the major dense lines and the intraperiod spaces give compact myelin its characteristic ultrastructural appearance (Figure <xref ref-type="fig" rid="F3">3A</xref>). In mature CNS myelin, a single channel of cytoplasm remains around the perimeter of the glial cell process, and live imaging of Lucifer yellow filled oligodendrocytes in <italic>ex vivo</italic> spinal cord slices suggests that additional transient openings are present through the compact myelin (Velumian et al., <xref ref-type="bibr" rid="B213">2011</xref>). Together, these cytoplasm-filled spaces constitute the non-compact myelin or “myelinic channel” system. In the PNS, this includes Schmidt-Lanterman incisures (SLI), which connect the Schwann cell abaxonal cytoplasm with the periaxonal cytoplasm (Ghabriel and Allt, <xref ref-type="bibr" rid="B64">1981</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p><bold>(A)</bold> Electron micrograph showing the multilayered myelin sheath of a CNS axon in cross section. Note the regular periodicity of compact myelin, which is composed of the major dense line, reflecting the fused intracellular glial surfaces (white dots), and the 2 nm wide intraperiod space between the extracellular surfaces of adjacent wraps (blue dots). Arrows point to radial components. <bold>(B)</bold> In mature CNS, a single cytoplasmic channel is present around the perimeter of the glial cell process (light green), which is best understood, if the myelin is virtually unwrapped (schematically demonstrated for one internodal segment). The cytoplasmic channel connects the glial cell soma with the most distal part of the myelin sheath and contains organelles and cytoskeletal elements, as shown in <bold>C</bold>. <bold>(C)</bold> Electron micrograph of CNS paranodal loops, abutting the axon. These contain microtubules (arrows) and vesicles (arrowheads). (<bold>A,C</bold> were reproduced from Edgar and Griffiths, <xref ref-type="bibr" rid="B45">2013</xref>, in Diffusion MRI, From Quantitative Measurement to <italic>in vivo</italic> Neuroanatomy; published by Elsevier).</p>
</caption>
<graphic xlink:href="fnins-12-00467-g0003"></graphic>
</fig>
<p>The myelinic channel, which we suggest plays an important role in glial-mediated axonal maintenance (see Mechanisms of injury: axonal pathology caused by oligodenroglial defects), is best understood if the myelin sheath is “virtually unwrapped” (Figure <xref ref-type="fig" rid="F3">3B</xref>). It provides continuity between the cell soma and the distal-most part of the myelin sheath at the glial-axonal junction (Ransom et al., <xref ref-type="bibr" rid="B155">1991</xref>), and contains septin filaments (Buser et al., <xref ref-type="bibr" rid="B24">2009</xref>; Patzig et al., <xref ref-type="bibr" rid="B140">2016</xref>), microtubules, vesicles (the last two illustrated in Figure <xref ref-type="fig" rid="F3">3C</xref>) and multivesicular bodies. Ion channels, glutamate receptors and metabolic transporters (e.g., monocarboxylate transporter 1) are located on its adaxonal surface (Rinholm et al., <xref ref-type="bibr" rid="B162">2011</xref>; Lee et al., <xref ref-type="bibr" rid="B104">2012b</xref>; Nijland et al., <xref ref-type="bibr" rid="B132">2014</xref>; Domenech-Estevez et al., <xref ref-type="bibr" rid="B41">2015</xref>; Saab et al., <xref ref-type="bibr" rid="B171">2016</xref>). The myelin sheath is separated from the <bold>axolemma</bold> by the periaxonal space, an ~15 nm wide space (Peters, <xref ref-type="bibr" rid="B147">1966</xref>) filled with extracellular fluid that reaches it through a spiralling pathway between the paranodal loops (reviewed in Rosenbluth, <xref ref-type="bibr" rid="B166">2009</xref>). Taken together, the myelin sheath comprises a tightly wrapped double-layered cell process that is connected to its cell body via a system of fluid-filled channels.</p>
</sec>
<sec>
<title>The myelination of axons was critical in the evolution of higher species</title>
<p>In the vertebrate central nervous system (CNS), myelinated axons define white matter tracts, including the corpus callosum, optic nerves, and spinal cord dorsal and ventral columns, which together account for ~40% of CNS volume in humans (Morell, <xref ref-type="bibr" rid="B122">1984</xref>); a higher proportion than in other species, reflecting the fact that “connectional elaboration” (= the expansion of neuronal connectivity) was key in human brain evolution (Schoenemann et al., <xref ref-type="bibr" rid="B176">2005</xref>). In the peripheral nervous system (PNS), myelinated axon bundles constitute peripheral nerves, such as the sciatic nerve and the sural nerve, which link the CNS to peripheral targets. The optic nerve, being a CNS white matter tract, is erroneously named. One of the key differences between CNS and PNS axons is that in the adult, the former do not regenerate after injury.</p>
<p>The evolution of a rapidly functioning, yet complex nervous system was the prerequisite for development of cognitive function in higher vertebrate species. Acceleration of nerve conduction velocity can be achieved through two basic mechanisms (Hartline and Colman, <xref ref-type="bibr" rid="B76">2007</xref>a). Expansion of axonal caliber, whilst effective in invertebrates with only a few nerve fibers, such as the giant axon of the squid, and the Mauthner axon in lower vertebrates, is not viable in higher vertebrates with large number of axons and consequent space restrictions. Here, glial cells adapted to insulate the axon with a multi-lamellar, concentrically wrapped membrane, termed the myelin sheath (Hartline and Colman, <xref ref-type="bibr" rid="B76">2007</xref>; Nave and Werner, <xref ref-type="bibr" rid="B127">2014</xref>). In vertebrates, myelin emerged first in cartilaginous fish and is functionally homologous with, but morphologically distinct from, myelin-like glial ensheathments in annelids and crustacea, (Hartline and Colman, <xref ref-type="bibr" rid="B76">2007</xref>; Zalc et al., <xref ref-type="bibr" rid="B234">2008</xref>). Non-myelinating axon-ensheathing cells exist in virtually all nervous systems (Schweigreiter et al., <xref ref-type="bibr" rid="B177">2006</xref>).</p>
<p>In adult vertebrate CNS, axons larger than the ~0.2 μm diameter “threshold” for myelination (Lee et al., <xref ref-type="bibr" rid="B103">2012a</xref>; Goebbels et al., <xref ref-type="bibr" rid="B70">2017</xref>) are surrounded by <bold>compact myelin</bold>, which is produced by oligodendrocytes. Oligodendrocyte precursors (OPCs), being present throughout life, can restore myelin sheaths following demyelination (Zawadzka et al., <xref ref-type="bibr" rid="B236">2010</xref>) and potentially contribute to myelin turnover (Xiao et al., <xref ref-type="bibr" rid="B228">2016</xref>). In the PNS, Schwann cells myelinate axons above a threshold size of ~1 μm diameter (Voyvodic, <xref ref-type="bibr" rid="B215">1989</xref>), whilst non-myelinating Schwann cells ensheath multiple small calibre axons within so-called “Remak bundles”.</p>
</sec>
<sec>
<title>Myelinated axons and associated cells constitute CNS white matter and PNS nerves</title>
<p>Within a tract or nerve, axons are packed densely and (in general) aligned in parallel. This arrangement admits the application of diffusion tensor imaging, a magnetic resonance technique used in larger brains to map fibre tracts and identify white matter changes. Axonal densities vary from one tract to another depending largely on axonal diameter and myelination status; for example, from ~70 to ~380 axons per 100 μm<sup>2</sup> in cross-sections of the hippocampal commissure and basal telencephalic commissures of the adult rhesus monkey (LaMantia and Rakic, <xref ref-type="bibr" rid="B100">1990</xref>). Estimates suggest that in mice, the optic nerve and corpus callosum respectively, contain ~50,000 (Edgar et al., <xref ref-type="bibr" rid="B46">2010</xref>) and 300,000 (Tomasch and Macmillan, <xref ref-type="bibr" rid="B200">1957</xref>) axons in total; in humans the corresponding values are ~1 and ~800 million (Koppel and Innocenti, <xref ref-type="bibr" rid="B98">1983</xref>; Mikelberg et al., <xref ref-type="bibr" rid="B117">1989</xref>).</p>
<p>Fibre tracts comprise other important cellular elements including microglia or macrophages, which provide immune surveillance in the CNS and PNS, respectively (Perry and Gordon, <xref ref-type="bibr" rid="B144">1988</xref>; Klein and Martini, <xref ref-type="bibr" rid="B96">2016</xref>), and astrocytes in the CNS, the processes of which often surround axons (Luse, <xref ref-type="bibr" rid="B110">1956</xref>). Blood vessels, which perfuse fibre tracts, are lined by endothelial cells and associated with pericytes, smooth muscle cells and fibroblast-like cells. In humans, but not rodents, a number of neuronal cell bodies reside in the CNS white matter (Suarez-Sola et al., <xref ref-type="bibr" rid="B193">2009</xref>).</p>
</sec>
<sec>
<title>Axonal dimensions</title>
<p>Neurons have a single axon and these vary greatly in length as well as in ramification, as indicated before (Wu et al., <xref ref-type="bibr" rid="B225">2014</xref>; Economo et al., <xref ref-type="bibr" rid="B44">2016</xref>). In larger animals, axons of projection neurons can reach many meters in length (Wu et al., <xref ref-type="bibr" rid="B225">2014</xref>; Wedel, <xref ref-type="bibr" rid="B222">2018</xref>). This is particularly remarkable considering mammalian axons are &lt;20 μm in diameter and their neuronal cell bodies are only some tens of microns across. In both the CNS and PNS, a range of diameters exists within and between tracts/nerves such that axons of a given length can differ in diameter ~100-fold and thus 10,000-fold by volume. Measured diameters range from &lt;0.1 to &gt;10 μm in the CNS and from ~0.1 to ~20 μm in the PNS, in mice (reviewed in Susuki, <xref ref-type="bibr" rid="B195">2010</xref>; Edgar and Griffiths, <xref ref-type="bibr" rid="B45">2013</xref>). Individual PNS nerves generally contain a wide range of axonal diameters and whilst this is also the case in the spinal cord lateral and ventral (anterior in human) columns, some CNS tracts, such as the corpus callosum, optic nerve and spinal cord dorsal (posterior in human) columns, contain predominantly small diameter axons. Physically, the most critical determinant of the calibre of a mature axon is the phosphorylation status of its medium neurofilaments (NFM; see The axonal cytoskeleton; reviewed by Kirkcaldie and Dwyer, <xref ref-type="bibr" rid="B92">2017</xref>).</p>
<p>What is the reason for the range of diameters? Although conduction velocity increases with axonal diameter, the outcome is likely inconsequential in shorter axons and it has been speculated that information rate, which is dependent on firing rate, and consequently with axonal volume and energy use, is the crucial determinant of axonal diameter; with evolutionary pressure toward thin diameters due to space and energy constraints (Perge et al., <xref ref-type="bibr" rid="B143">2012</xref>). Nonetheless, axonal diameter is not absolutely constant along the axon's length. In addition to consistent narrowing at the <bold>node</bold> and <bold>paranode</bold> (see The axonal cytoskeleton), the diameter of an individual axon fluctuates over its length (Perge et al., <xref ref-type="bibr" rid="B143">2012</xref>) probably as a transient response to the movement of ions (Trigo and Smith, <xref ref-type="bibr" rid="B205">2015</xref>).</p>
</sec>
<sec>
<title>Axon initial segment</title>
<p>The axon initial segment (AIS) is a specialized, non-myelinated region at the very proximal end of the myelinated axon at which action potentials are initiated. At the AIS, the <bold>axolemma</bold> is densely populated with ion channels including Nav channels and neuronal KCNQ potassium channels (reviewed in Dumenieu et al., <xref ref-type="bibr" rid="B43">2017</xref>). Thus, over its 10–60 μm length, the AIS is similar in several respects to the <bold>node of Ranvier</bold>, including cytoskeletal arrangements. The AIS of mature CNS neurons helps maintain neuronal polarisation by acting as a selective sieve that restricts the movement of proteins from the somatodendritic compartment into the axon (Franssen et al., <xref ref-type="bibr" rid="B57">2015</xref>).</p>
</sec>
<sec>
<title>Components of nodal/paranodal specialisations (CNS/PNS)</title>
<p>Distal to the AIS and at both ends of a myelin sheath (Figures <xref ref-type="fig" rid="F1">1C,D</xref>, <xref ref-type="fig" rid="F3">3B</xref>), the paranodal loops (part of the myelinic channel system) tightly appose the axon and the two are tethered by <bold>septate</bold>-like junctions, formed by Neurofascin 155 on the glial side and Contactin and Caspr on the axonal side (Charles et al., <xref ref-type="bibr" rid="B27">2002</xref>). The node of Ranvier is the small amyelinated space between the outermost paranodal loops of adjacent myelin sheaths, whilst the juxtaparanode lies between the innermost paranodal loop and the internode proper (Figures <xref ref-type="fig" rid="F1">1C,D</xref>). In both the adult CNS and PNS, Nav1.6 Na<sup>+</sup> channels are located at the <bold>node of Ranvier</bold> and Kv1.1, Kv1.2 K<sup>+</sup> channels are localised to the <bold>juxtaparanodal</bold> region; although others are also present (Dumenieu et al., <xref ref-type="bibr" rid="B43">2017</xref>). Various anchoring molecules including β IV spectrin and Ankyrin G as well as the paranodal-axonal transverse bands (forming <bold>septate</bold>-like junctions) restricts electrical activity to the nodal compartment and hinder lateral diffusion of these and other axonal membrane proteins (Rosenbluth, <xref ref-type="bibr" rid="B166">2009</xref>). For detailed reviews see Rasband and Peles (<xref ref-type="bibr" rid="B157">2015</xref>) and Dumenieu et al. (<xref ref-type="bibr" rid="B43">2017</xref>). A recent study suggests that adjustment of node of Ranvier length might represent a rapid and energy-efficient mechanism for tuning the arrival time of information to its target, by altering conduction speed (Arancibia-Carcamo et al., <xref ref-type="bibr" rid="B4">2017</xref>).</p>
<p>Although CNS and PNS nodal/paranodal structures are similar in several respects, important morphological differences include the covering of the nodal space. In the PNS, Schwann cells form the basal lamina that bridges the node, and Schwann cell microvilli contact the nodal area. In the CNS, some nodes are covered by perinodal astrocytes or OPC processes (reviewed in Rasband and Peles, <xref ref-type="bibr" rid="B157">2015</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>Axo-glial signalling, axonal maintenance, and energy metabolism</title>
<sec>
<title>Cell autonomous and bi-directional signalling regulate axon and myelin dimensions</title>
<p>Distal to the AIS, the axon and the cells that myelinate it form a “symbiotic” unit. Each one uses both cell autonomous and bi-directional signaling mechanisms to initiate myelination and finely tune nodal and internodal (see Components of nodal/paranodal specialisations) dimensions to ensure the timely arrival of action potentials at the nerve terminus (Rushton, <xref ref-type="bibr" rid="B170">1951</xref>; Stanford, <xref ref-type="bibr" rid="B191">1987</xref>). Several recent studies have provided mechanistic insight to the molecular and cyto-architectural changes that take place in the myelinating cell during axonal engagement and wrapping, and this literature has been extensively reviewed elsewhere (Bauer et al., <xref ref-type="bibr" rid="B12">2009</xref>; Snaidero and Simons, <xref ref-type="bibr" rid="B183">2014</xref>; Hughes and Appel, <xref ref-type="bibr" rid="B79">2016</xref>; Tricaud, <xref ref-type="bibr" rid="B204">2017</xref>).</p>
<p>In the CNS, a neuronal “switch”, the PI3K–AKT1–mTOR pathway, may be sufficient to trigger radial axonal growth, recruitment of OPCs and progressive myelination, as suggested from the phenotype of PTEN-deficient granule cell neurons and their (ectopically) myelinated parallel fiber axons (Goebbels et al., <xref ref-type="bibr" rid="B70">2017</xref>). The wrapping of the oligodendrocyte process around the axon (the final number of wraps determines the thickness of the myelin sheath) and the extension of myelin along its length (determining internodal length) are intrinsically determined by glia growth, but modulated by the diameter of the axon they wrap (Bechler et al., <xref ref-type="bibr" rid="B13">2015</xref>). Recently it was suggested that axons effect precise regulation of myelin formation by dictating the targeting of mRNAs to specific subcellular locations within the myelinating cell. Indeed, localised protein synthesis in OPCs is triggered by axonal action potentials (Wake et al., <xref ref-type="bibr" rid="B216">2011</xref>). Correspondingly, electrically active axons are preferentially myelinated and neural activity probably also promotes myelin plasticity in the adult (reviewed in Almeida and Lyons, <xref ref-type="bibr" rid="B2">2017</xref>; Bechler et al., <xref ref-type="bibr" rid="B14">2018</xref>). Thus, whereas myelination is largely driven intrinsically in oligodendrocytes (Lee et al., <xref ref-type="bibr" rid="B103">2012a</xref>), it can be modulated by extrinsic factors including electrical activity of axons, acting via oligodendroglial calcium transients (Baraban et al., <xref ref-type="bibr" rid="B10">2018</xref>; Krasnow et al., <xref ref-type="bibr" rid="B99">2018</xref>), the glutamatergic stimulation of glucose uptake (Saab et al., <xref ref-type="bibr" rid="B171">2016</xref>) and other extracellular signalling molecules (Lundgaard et al., <xref ref-type="bibr" rid="B109">2013</xref>; Emery and Lu, <xref ref-type="bibr" rid="B50">2015</xref>).</p>
<p>Notably, axonal ensheathment, radial myelin growth and myelin elongation are controlled by different mechanisms in the PNS. Prior to myelination, Schwann cells separate single axons into a stable one-to-one relationship in a process called “axonal sorting”. The established axon-myelin unit then grows in size, reaching up to 1 mm or more in internodal length (Hildebrand et al., <xref ref-type="bibr" rid="B77">1994</xref>). Recently, a role for the Hippo pathway and YAP/TAZ in the integration of mechanical signals and myelination emerged in Schwann cells and has been linked to longitudinal myelin growth during development (Fernando et al., <xref ref-type="bibr" rid="B54">2016</xref>; Poitelon et al., <xref ref-type="bibr" rid="B150">2016</xref>). The <bold>g-ratio</bold>, which is a measure of the relationship between axonal diameter and myelin sheath thickness, is relatively constant for CNS and PNS axons of all diameters (Donaldson and Hoke, <xref ref-type="bibr" rid="B42">1905</xref>). In the PNS, a threshold level of neuregulin on axons is required for myelin initiation and the total level of neuregulin on the axon's surface dictates the thickness of the myelin sheath (Michailov et al., <xref ref-type="bibr" rid="B116">2004</xref>; Taveggia et al., <xref ref-type="bibr" rid="B198">2005</xref>). Neuregulin1 downstream signaling involves PI3K/AKT and MEK/ERK pathway activation, both of which have been shown to be crucial for myelination in the PNS (Taveggia, <xref ref-type="bibr" rid="B197">2016</xref>). In addition to the essential role of neuregulin1 for Schwann cell development and myelination, numerous other extrinsic and intrinsic signaling cues have been shown to regulate myelin sheath formation in the PNS, including ADAM secretases, Notch signaling and Nectin proteins (Pereira et al., <xref ref-type="bibr" rid="B141">2012</xref>; Monk et al., <xref ref-type="bibr" rid="B120">2015</xref>; Taveggia, <xref ref-type="bibr" rid="B197">2016</xref>).</p>
<p>Reciprocally, oligodendrocytes and Schwann cells contribute to axonal outcomes such as the initial clustering and maintenance of sodium and potassium channels at the <bold>node of Ranvier</bold> and <bold>juxtaparanode</bold>, respectively (see Components of nodal/paranodal specialisations and Figure <xref ref-type="fig" rid="F1">1</xref>). Myelin also locally increases axonal calibre by modulating axonal neurofilament transport, as demonstrated by dynamic imaging <italic>in vitro</italic> (Uchida et al., <xref ref-type="bibr" rid="B207">2013</xref>; Monsma et al., <xref ref-type="bibr" rid="B121">2014</xref>), and phosphorylation and spacing (see The axonal cytoskeleton; Yuan et al., <xref ref-type="bibr" rid="B232">2017</xref>), as evidenced by electron microscopic analysis of myelin-deficient <italic>shiverer</italic> mutant mice; although the responsible signalling mechanisms are not well understood. A stabilizing effect of mature myelin on the neuronal cytoskeleton is mediated in part by the myelin associated glycoprotein (MAG) which requires two axonal receptor families: sialoglycans (particularly the gangliosides GD1a and GT1b) and members of the Nogo receptor (NgR) family (Yin et al., <xref ref-type="bibr" rid="B231">1998</xref>). Myelin and/or myelinating cells also influence the density of axonal mitochondria, such that non-myelinated axons and the axon initial segment (AIS) have a higher density of mitochondria than myelinated <bold>internodes</bold> (Bristow et al., <xref ref-type="bibr" rid="B22">2002</xref>; Andrews et al., <xref ref-type="bibr" rid="B3">2006</xref>).</p>
</sec>
<sec>
<title>Axonal transport</title>
<p>Following the establishment of nodal/paranodal specialisations, nodal ion channels turn over slowly and are replenished by motor protein driven transport (Zhang et al., <xref ref-type="bibr" rid="B238">2012</xref>). Neurons, being extremely polarised, are very dependent upon intracellular transport for the delivery and removal of proteins and organelles. ATP-dependent motor proteins utilise microtubules to transport these cargoes. Members of the extended kinesin superfamily, including kinesin-1, kinesin-2, and kinesin-3, transport their cargoes anterogradely (i.e., towards the microtubule plus-end) whilst dynein-1, in complex with its activator dynactin, is responsible for most retrograde (microtubule minus–end directed) transport. Until relatively recently, the movement of cargoes in myelinated axons <italic>in vivo</italic> was inferred from biochemical studies using radioactive tracers to label newly synthesised proteins, or from live imaging of cargoes in non-myelinated axons in culture, reviewed in Brauckmann (<xref ref-type="bibr" rid="B21">2004</xref>). Recently however, live imaging of the movement of mitochondria, peroxisomes or signalling endosomes in myelinated axons <italic>in vivo</italic>, has been achieved (Sorbara et al., <xref ref-type="bibr" rid="B187">2014</xref>; Sleigh et al., <xref ref-type="bibr" rid="B179">2017</xref>).</p>
<p>Classically, axonal transport is divided into “fast” and “slow” according to the bulk speeds of cargo movement. For example, vesicles and mitochondria move fast at a rate of ~1 μm s<sup>−1</sup>, whereas cytoskeletal components translocate slowly at speeds of ~1 mm per day; the difference being due to longer intermittent “stationery” phases of the cytoskeletal elements (Roy et al., <xref ref-type="bibr" rid="B168">2000</xref>; Wang et al., <xref ref-type="bibr" rid="B220">2000</xref>; Wang and Brown, <xref ref-type="bibr" rid="B219">2002</xref>). Axonal transport is a highly regulated process, which is still poorly understood; motor proteins must recognise and bind specific cargoes, deliver these to the appropriate sites (e.g., the <bold>node of Ranvier</bold>, synapse, <bold>internode</bold>), change directions at axonal branch points, and offload cargo according to need. Regulation occurs, at least in part, through organelle-associated scaffolding proteins that bind to regulatory proteins, including kinases and GTPases, (reviewed in Fu and Holzbaur, <xref ref-type="bibr" rid="B58">2014</xref>). Not surprisingly, transport is susceptible to perturbation following changes to motors, their regulators (Morfini et al., <xref ref-type="bibr" rid="B123">2009</xref>), tracks, fuel supply and/or cargoes themselves, and manifests as organelle filled axonal swellings, neurofilament-filled swellings, thinning of the axon and/or axonal degeneration. Of note, demyelinating conditions were shown to impact anterograde axonal transport in the PNS (De Waegh et al., <xref ref-type="bibr" rid="B37">1992</xref>), but the analysis of specific oligodendrocyte defects later revealed that the modulation of fast and slow transport in the CNS might be a glial function independent of myelin (Kirkpatrick et al., <xref ref-type="bibr" rid="B94">2001</xref>; Edgar et al., <xref ref-type="bibr" rid="B49">2004</xref>).</p>
</sec>
<sec>
<title>Energy use and supply</title>
<p>Axonal transport is an energy-dependent process that contributes to the brain's total energy consumption. The human brain, which occupies ~2% of the body's mass, consumes ~20% of its resting energy production (reviewed in Engl and Attwell, <xref ref-type="bibr" rid="B51">2015</xref>) and white matter is estimated to consume around one third of the energy of grey matter (Sokoloff et al., <xref ref-type="bibr" rid="B186">1977</xref>). A large proportion of the white matter's energy consumption is used by neurons to pump out sodium ions using energy-dependent Na<sup>+</sup>-K<sup>+</sup>-ATPases on the internodal axolemma, (reviewed in Engl and Attwell, <xref ref-type="bibr" rid="B51">2015</xref>). In axons, the turnover of actin and microtubules (Engl et al., <xref ref-type="bibr" rid="B52">2017</xref>), the phosphorylation of neurofilaments and the movement of cargo-bearing motor proteins (see Axonal transport) represent additional energy-consuming functions.</p>
<p>Molecular motors utilise 1 molecule of ATP per 8 nm step (reviewed in Maday et al., <xref ref-type="bibr" rid="B112">2014</xref>). However, dyneins are less efficient than kinesins because they take more backward steps. It has been estimated that a single vesicle traversing a 1 m long human motor neuron from neuromuscular junction back to the soma or vice versa would require a minimum of 7.5 × 10<sup>8</sup> ATP or ~1.25 × 10<sup>8</sup> ATP molecules, respectively (Maday et al., <xref ref-type="bibr" rid="B112">2014</xref>). At an average rate of 1 μm s<sup>−1</sup>, this represents 7.5 × 10<sup>2</sup> or 1.25 × 10<sup>2</sup> ATP s<sup>−1</sup>. Based on 2 motile organelles per 10 μm axonal length (the maximum length of an axonal mitochondrion), 50% moving anterogradely and 50% moving retrogradely, transport would utilise ~8.75 × 10<sup>7</sup> ATP s<sup>−1</sup> per 1 m long axon. This equates to ~6.29 × 10<sup>−5</sup> g of glucose per 24 h for a human sciatic nerve containing 1,000,000 axons. Importantly, these calculations are based on a very rough approximation of organelle numbers from our own electron microscopy images; assume only 1–2 motors simultaneously hydrolysing ATP per organelle; and no “tug-of-war” or “switch” events (Maday et al., <xref ref-type="bibr" rid="B112">2014</xref>). In comparison, an estimated 1.54 × 10<sup>9</sup> molecules of ATP s<sup>−1</sup> per cortical neuron in the rodent brain is used in action potential generation and propagation (Attwell and Laughlin, <xref ref-type="bibr" rid="B6">2001</xref>).</p>
<p>Whilst glucose is the main substrate for feeding the TCA cycle and for ATP production in the nervous system (Hui et al., <xref ref-type="bibr" rid="B80">2017</xref>), it has been demonstrated experimentally, <italic>ex vivo</italic> and <italic>in vivo</italic>, that pyruvate or lactate can sustain neuronal function, even over several hours of high level activity (Brown et al., <xref ref-type="bibr" rid="B23">2001</xref>; Wyss et al., <xref ref-type="bibr" rid="B227">2011</xref>; Trevisiol et al., <xref ref-type="bibr" rid="B203">2017</xref>). What are the implications? Pyruvate and lactate are the 3-carbon products of glycolysis; lactate classically being generated from pyruvate to maintain NAD<sup>+</sup>, and thus sustain glycolysis when oxygen levels are low. However, some cells synthesise most of their ATP by glycolysis even when oxygen is plentiful (Vander Heiden et al., <xref ref-type="bibr" rid="B211">2009</xref>), especially in situations where cell growth is involved, such as development or cancer. Nonetheless, glycolysis yields only 2 molecules of ATP per 6-carbon glucose molecule and it is thought that most mammalian cells depend additionally on oxidative phosphorylation (OXPHOS; yielding ~36 molecules of ATP per glucose) to meet their energy requirements. Indeed, neurons fail to survive if OXPHOS is prevented genetically (Fukui et al., <xref ref-type="bibr" rid="B59">2007</xref>; Funfschilling et al., <xref ref-type="bibr" rid="B60">2012</xref>). Therefore the observation that astrocytes and post-myelination oligodendrocytes could survive as completely “glycolytic” cells (Funfschilling et al., <xref ref-type="bibr" rid="B60">2012</xref>; Supplie et al., <xref ref-type="bibr" rid="B194">2017</xref>) came as a surprise; although the suggestion that astrocytes (which can store glucose as glycogen) supply lactate to neurons to support their synaptic functions metabolically and when glucose supplies are low, is well-established (reviewed in Barros and Weber, <xref ref-type="bibr" rid="B11">2018</xref>). More recently we proposed that glycolytic oligodendrocytes could similarly fuel ATP synthesis in axonal mitochondria with lactate (Funfschilling et al., <xref ref-type="bibr" rid="B60">2012</xref>). Indeed, the monocarboxylate transporters MCT-1 and MCT-2 (which transport monocarboxylates including pyruvate and lactate) are appropriately located on the adaxonal glial cell membrane and on the axolemma, respectively (summarised schematically in Figure <xref ref-type="fig" rid="F4">4D</xref>, Funfschilling et al., <xref ref-type="bibr" rid="B60">2012</xref>), and normal levels of MCT-1 in oligodendrocytes are required to maintain axonal integrity in the CNS (Lee et al., <xref ref-type="bibr" rid="B104">2012b</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Morphological characteristics of white matter in mouse “myelin mutants”. <bold>(A)</bold> Normal myelinated optic nerve axons. <bold>(B)</bold> In the <italic>shiverer</italic> mouse, oligodendrocytes lacking myelin basic protein (MBP) are not able to form compact myelin, though a few loose myelin-like wraps are observed. Note the increased oligodendrocytic processes (asterisk). AS: Astrocyte process. <bold>(C,D)</bold> In contrast, the CNP<sup><italic>null</italic></sup> mouse produces compact myelin but develops pronounced axonal swellings (asterisks in <bold>C</bold>) and enlarged inner tongues (arrowheads in <bold>D</bold>).</p>
</caption>
<graphic xlink:href="fnins-12-00467-g0004"></graphic>
</fig>
<p>Why would myelinating glia act as local fuelling stations for axonal mitochondria? Possible answers are that axons require much more energy than glia and that the barrier-like properties of the myelin sheath, which play such an important role in axonal insulation, likely hamper axonal glucose uptake from the extracellular space (Nave, <xref ref-type="bibr" rid="B126">2010b</xref>).</p>
<p>If indeed glucose is prevented from reaching the myelinated axon, then the ATP to fuel axonal energy requirements should come from the oxidative phosphorylation of glial cell glycolysis products. However, a 2013 study in <italic>Drosophila</italic> larvae reported that the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is localised to axonal transport vesicles (via a huntingtin-dependent mechanism), and that vesicular transport is supported by glycolytic ATP generation (Zala et al., <xref ref-type="bibr" rid="B233">2013</xref>). Subsequently, the same authors found that a mouse forebrain fraction enriched in neuronally-derived motile vesicles was associated with 8 of 10 glycolytic enzymes and could synthesise ATP <italic>in vitro</italic> when appropriate substrates were added (Hinckelmann et al., <xref ref-type="bibr" rid="B78">2016</xref>). These data suggest that, in some neurons, the transport of vesicles can be autonomous in terms of ATP synthesis. However, subsequent studies in <italic>Drosophila</italic>, using cell-specific gene silencing (Volkenhoff et al., <xref ref-type="bibr" rid="B214">2015</xref>), confirmed also the principle of division of labour between neurons (requiring OXPHOS but no glycolysis) and glycolytic glial cells (requiring glycolysis but not OXPHOS) and revealed a remarkable evolutionary conservation of metabolic support.</p>
</sec>
</sec>
<sec id="s4">
<title>General pathology and mechanisms of axonal injury</title>
<p>The unique architectural features and metabolic requirements of myelinated fibers make their axons particularly susceptible to injury from a range of diverse causes; including physical trauma, oxygen and glucose deprivation, inflammation and the consequence of gene mutations. Axonal degeneration is also an early feature of classical neurodegenerative diseases associated with characteristic pathologies of neuronal somata, such as Alzheimer's.</p>
<p>Axonal injury, with or without frank axonal transection can (but does not inevitably) lead to neuronal dysfunction, depending amongst other things, on the site of injury relative to axonal branch points. Clinical signs and symptoms thus reflect both the white matter tract affected and the location of injury within the tract, as observed in spinal cord injury. Below we summarize what we have learned about general mechanisms of axonal injury and degeneration from human and animal studies, but note that the mechanisms described are not necessarily distinct. For example, dying back axonopathies can also involve Wallerian-like mechanisms (Coleman, <xref ref-type="bibr" rid="B29">2005</xref>).</p>
<sec>
<title>Mechanisms of injury: wallerian degeneration</title>
<p>Wallerian degeneration (WD) was described over 150 years ago by August Waller (<xref ref-type="bibr" rid="B218">1850</xref>), and represents the degeneration of the axon distal to injury and the subsequent clearance of axonal debris. Classically, WD is induced by physical axotomy (nerve cut) of a fiber tract, as for example in spinal cord injury and peripheral nerve trauma, but genetic evidence shows that a Wallerian-like mechanism also occurs in response to other forms of axonal injury such as “dying back” degeneration in peripheral neuropathies, and potentially in CNS axonal dystrophies in humans, as suggested from studies in mouse models (reviewed in Coleman, <xref ref-type="bibr" rid="B29">2005</xref>; Conforti et al., <xref ref-type="bibr" rid="B31">2014</xref>). Notably, although the rates of WD in PNS and CNS are similar, the clearance of debris by resident microglia in the CNS can take months to years, compared with a few days in the PNS (Perry et al., <xref ref-type="bibr" rid="B145">1987</xref>; and reviewed in Vargas and Barres, <xref ref-type="bibr" rid="B212">2007</xref>). In the PNS, Schwann cells contribute to the removal of myelin debris via a form of selective autophagy (Gomez-Sanchez et al., <xref ref-type="bibr" rid="B71">2015</xref>; Jang et al., <xref ref-type="bibr" rid="B82">2016</xref>). Efficient debris removal constitutes a prerequisite for subsequent regeneration in both the PNS and CNS and the failure of axonal regeneration after injury in the CNS has been linked to the presence of myelin-associated inhibitors of axonal regrowth at the injury site (reviewed in Vargas and Barres, <xref ref-type="bibr" rid="B212">2007</xref>).</p>
<p>WD involves the remarkable process of active subcellular self-destruction. It is tightly regulated; involving a first latent phase (around 1.5–2 days post-axotomy in rodents) in which axons remain morphologically and metabolically intact and a second phase involving final breakdown of structural proteins and axonal fragmentation (reviewed in Gerdts et al., <xref ref-type="bibr" rid="B63">2016</xref>). This second step is accompanied by reactive glial changes and immune cell activation (Beuche and Friede, <xref ref-type="bibr" rid="B17">1984</xref>; Scheidt and Friede, <xref ref-type="bibr" rid="B174">1987</xref>). In the PNS, these changes, especially the injury-response of Schwann cells, are the prerequisite of successful repair (Arthur-Farraj et al., <xref ref-type="bibr" rid="B5">2012</xref>).</p>
<p>The Wallerian degeneration slow (<italic>Wlds</italic>) mouse was discovered serendipitously ~30 years ago (Perry et al., <xref ref-type="bibr" rid="B146">1990</xref>) yet, despite the plethora of studies aimed at elucidating it, the mechanism of delayed axonal degeneration is still not fully understood (reviewed in Gerdts et al., <xref ref-type="bibr" rid="B63">2016</xref>). The <italic>Wlds</italic> mutation comprises a tandem triplication resulting in the fusion of two genes (Coleman et al., <xref ref-type="bibr" rid="B30">1998</xref>), the product of which is a novel chimeric protein composed of the NAD<sup>+</sup> biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) and a fragment of the ubiquitin ligase, Ube4b (Mack et al., <xref ref-type="bibr" rid="B111">2001</xref>). NMNAT1 activity and a short N-terminal sequence are together required for the Wallerian degeneration slow effect (Avery et al., <xref ref-type="bibr" rid="B7">2009</xref>; Conforti et al., <xref ref-type="bibr" rid="B32">2009</xref>); most likely the extraneous NMNAT1 compensates for another NMNAT enzyme (NMNAT2) in the distal axon. NMNAT2 traffics anterogradely from the cell body into the distal axon, thus its depletion after injury (being unable to reach the axon distal to the injury and having a short half-life) is thought to initiate axonal self-destruction (Gilley and Coleman, <xref ref-type="bibr" rid="B67">2010</xref>). Of note, a genetic knockout of <italic>Nmnat2</italic> is embryonic lethal, however, the phenotype is rescued <italic>in vivo</italic> upon generation of a double knockout of <italic>Nmnat2</italic> and <italic>Sarm1</italic> (Gilley et al., <xref ref-type="bibr" rid="B68">2015</xref>) resulting in a normal, healthy lifespan (Gilley et al., <xref ref-type="bibr" rid="B69">2017</xref>). Together, these observations led to the hypothesis that axonal depletion of NMNAT2 activates the intracellular, pro-degenerating protein SARM1 either (i) by increasing levels of NMN (the substrate for NMNAT, Di et al., <xref ref-type="bibr" rid="B39">2015</xref>, <xref ref-type="bibr" rid="B38">2017</xref>) and/or (ii) by decreasing NAD<sup>+</sup> in a feed-forward mechanism (Gerdts et al., <xref ref-type="bibr" rid="B62">2015</xref>; Sasaki et al., <xref ref-type="bibr" rid="B173">2016</xref>), initiating axonal self-destruction (Osterloh et al., <xref ref-type="bibr" rid="B137">2012</xref>; Gerdts et al., <xref ref-type="bibr" rid="B62">2015</xref>). Of note, SARM1 has recently shown to possess an intrinsic NAD<sup>+</sup> cleavage activity, which promotes axonal NAD<sup>+</sup> depletion and subsequent axonal degeneration (Essuman et al., <xref ref-type="bibr" rid="B53">2017</xref>). A complex interplay with other signaling cascades such as MAPK and JNK also contribute to the initiation phase (for more extensive reviews, see Conforti et al., <xref ref-type="bibr" rid="B31">2014</xref>; Gerdts et al., <xref ref-type="bibr" rid="B63">2016</xref>). For instance, the DLK/MAP3K12 gene has been shown to promote axonal degeneration downstream of jun kinase signaling (Miller et al., <xref ref-type="bibr" rid="B118">2009</xref>; Yang et al., <xref ref-type="bibr" rid="B230">2015</xref>). Moreover, MAPK signaling has been implicated in the turnover of NMNAT2, with MAPK limiting axonal NMNAT2 levels, thereby promoting axonal breakdown (Walker et al., <xref ref-type="bibr" rid="B217">2017</xref>). The transition between this early phase and the subsequent “execution phase” is thought to mark the point at which axons become committed to degenerate (Conforti et al., <xref ref-type="bibr" rid="B31">2014</xref>). It is now established that increased intra-axonal calcium together with calpain (a calcium-dependent protease) activation is crucial in the execution phase, leading to, amongst other things, neurofilament proteolysis and destabilization of microtubules (Zhai et al., <xref ref-type="bibr" rid="B237">2003</xref>; Conforti et al., <xref ref-type="bibr" rid="B31">2014</xref>; Loreto et al., <xref ref-type="bibr" rid="B107">2015</xref>; Gerdts et al., <xref ref-type="bibr" rid="B63">2016</xref>). Nonetheless, inhibition of calpain activation does not fully prevent the latter, indicating that additional Ca<sup>2+</sup>-dependent mechanisms contribute (Conforti et al., <xref ref-type="bibr" rid="B31">2014</xref>). Notably, other mechanisms and organelles are likely to be involved. Indeed, overexpression of the mitochondrial NMNAT3 isoform protects axons from Wallerian degeneration (Yahata et al., <xref ref-type="bibr" rid="B229">2009</xref>), and swelling and accumulation of axonal mitochondria at the paranodes represent early axonal changes in injury and disease models (for example, see Spencer and Schaumberg, <xref ref-type="bibr" rid="B189">1977a</xref>; Edgar et al., <xref ref-type="bibr" rid="B49">2004</xref>, and reviewed in Groh and Martini, <xref ref-type="bibr" rid="B73">2017</xref>).</p>
</sec>
<sec>
<title>Mechanisms of injury: dying back axonopathy</title>
<p>Dying back axonopathy is a neuropathological feature of a heterogenous group of toxic injuries and genetic defects, and generally involves long axons of the peripheral nerves and spinal cord. It is seen, for example, in Charcot-Marie-Tooth neuropathy, hereditary spastic paraplegia, giant axonal neuropathy (GAN), adrenomyeloneuropathy (AMN) and organophosphorus compound-induced delayed neurotoxicity (OPIDN). The last <bold>three</bold> have not been extensively reviewed elsewhere and are described briefly in Box<xref ref-type="boxed-text" rid="Box1">1</xref>–<xref ref-type="boxed-text" rid="Box3">3</xref>. The geometry of the susceptible axonal populations and the limitations of histological evaluation probably contributed to the misconception that, in contrast to WD, degeneration in the dying back disorders progresses retrogradely from the axonal terminus. Rather, it is likely that degeneration appears retrogradely progressing because at the level of the whole tract (comprising many axons), it is most prevalent distally (see Figure 1 of Coleman, <xref ref-type="bibr" rid="B29">2005</xref>). Indeed, early ultrastructural studies on hexacarbone induced neurotoxicity in rats, demonstrated that although a retrograde temporal spread of axonal swellings occurred, axonal degeneration was not initiated at the axon terminal nor spread centripetally along individual fibers (Spencer and Schaumberg, <xref ref-type="bibr" rid="B189">1977a</xref>,<xref ref-type="bibr" rid="B190">b</xref>). Nevertheless, axonal degeneration in these diseases seems length-dependent, pointing to a particular vulnerability of the long axons, possibly related to metabolic dysfunction or transport defects.</p>
<boxed-text id="Box1" position="float">
<label>Box 1</label>
<caption>
<title><bold>Organophosphorus (OP) compound-induced delayed neurotoxicity</bold>.</title>
</caption>
<p>OPIDN is an example of a pure axonal dying back neuropathy with a chemically induced degeneration of long, large-diameter sensorimotor axons in spinal cord and peripheral nerves, resulting in sensory loss and paralysis. In humans and susceptible animals, causes include occupational and accidental exposures to OP compounds (Smith and Spalding, <xref ref-type="bibr" rid="B181">1959</xref>). Indeed, “Jake leg palsy”, is attributed to consumption of tri-ortho-cresyl phosphate (TOCP)-adulterated Jamaican ginger extract during the Prohibition-era in the United States. Mechanistically, OP compounds inhibit serine esterases, including neuropathy target esterase (NTE), by organophosphorylation of the active site (Makhaeva et al., <xref ref-type="bibr" rid="B114">2013</xref>). Support for a role of this enzyme and its biochemical cascade in the molecular pathogenesis of OPIDN came from identification of mutations in NTE in autosomal recessive motor neuron degeneration (NTE-MND; Rainier et al., <xref ref-type="bibr" rid="B154">2008</xref>). Nonetheless, the mechanisms linking exposure to a neuropathic OP compound and the onset of OPIDN shortly after, are still poorly understood.</p>
</boxed-text>
<boxed-text id="Box2" position="float">
<label>Box 2</label>
<caption>
<title><bold>Giant axonal neuropathy</bold>.</title>
</caption>
<p>Giant axonal neuropathy (GAN; OMIM <ext-link ext-link-type="Omim" xlink:href="256850">256850</ext-link>) is an interesting example of a genetically-determined progressive axonopathy that, like OPIDN, affects both sensory and motor nerves in the PNS and CNS. GAN is a rare autosomal-recessive neurodegenerative disorder caused by mutations in the GAN gene (Bomont et al., <xref ref-type="bibr" rid="B18">2000</xref>), which encodes gigaxonin, a BTB-KELCH family member. GAN is characterized histologically by large axonal swellings filled with axonal intermediate filament (IF). Using dorsal root ganglia cultures, Israeli et al. (<xref ref-type="bibr" rid="B81">2016</xref>) demonstrated that gigaxonin is required for ubiquitin-proteasomal degradation of neuronal intermediate filaments (IF) and that IF accumulation impairs mitochondrial movement leading to metabolic and oxidative stress, implicating axonal energy insufficiency in this disorder. Symptom onset usually occurs in childhood and most patients die in the second or third decade (reviewed in Kang et al., <xref ref-type="bibr" rid="B85">2016</xref>).</p>
</boxed-text>
<boxed-text id="Box3" position="float">
<label>Box 3</label>
<caption>
<title><bold>Adrenomyeloneuropathy (AMN)</bold>.</title>
</caption>
<p>Adrenomyeloneuropathy (AMN) is caused by mutations in the X-linked gene for adenosine triphosphate binding cassette transporter (ABCD1) (Mosser et al., <xref ref-type="bibr" rid="B124">1993</xref>). This peroxisomal membrane protein is required for the import of very long-chain acyl CoA esters into peroxisomes for fatty acid β oxidation (van Roermund et al., <xref ref-type="bibr" rid="B210">2008</xref>). Symptom onset usually occurs in the 3rd decade and can present with or without cerebral involvement (see below). Neurological symptoms include a progressive ataxic gait and spastic paraparesis and most probably reflect the degeneration of long spinal cord axons (Pujol et al., <xref ref-type="bibr" rid="B153">2002</xref>). AMN is modelled in Abcd1 mutant mice, but the molecular mechanisms that link oligodendrocyte dysfunctions in β-oxidation to axonal degeneration remain to be established. A role of lipid-derived inflammatory mediators has been proposed (Kassmann and Nave, <xref ref-type="bibr" rid="B87">2008</xref>; Ruiz et al., <xref ref-type="bibr" rid="B169">2015</xref>) for both AMN and the allelic disorder X-linked adrenoleukodystrophy (X-ALD), a rapidly progressive inflammatory demyelinating disorder with onset in childhood or early adolescence (Kemp et al., <xref ref-type="bibr" rid="B89">2012</xref>).</p>
</boxed-text>
</sec>
<sec>
<title>Mechanisms of injury: focal axonal degeneration and inflammation-induced axonal dysfunction</title>
<p>Inflammation is a primary event in multiple sclerosis (MS), neuromyelitis optica (NMO) and Guillane-Barré syndrome (GBS; a peripheral neuropathy). GBS is characterised, based on electrophysiological assessment, as primarily “demyelinating” or “axonal” and is triggered by a wide range of preceding infections, notably Campylobacter. Recent work suggests that the acute peripheral neuropathy triggered by Zika virus infection (Cao-Lormeau et al., <xref ref-type="bibr" rid="B26">2016</xref>) might also be due to a GBS-like autoimmune response (see Box <xref ref-type="boxed-text" rid="Box4">4</xref>). MS, which is the best known inflammatory demyelinating disorder of the CNS, involves progressive axonal degeneration. Indeed, axonal and/or neuronal degeneration likely account for permanent neurological disability in secondary progressive MS. The causes of axonal injury in MS are still not known, and possibly include loss of trophic/metabolic support from oligodendrocytes, direct T-cell mediated injury, and energy insufficiency caused by soluble inflammatory factors (reviewed in Franklin et al., <xref ref-type="bibr" rid="B56">2012</xref>).</p>
<boxed-text id="Box4" position="float">
<label>Box 4</label>
<caption>
<title><bold>Zika virus infection</bold>.</title>
</caption>
<p>Zika virus is a neurotropic arbovirus of the family Flaviviridae that recently received considerable attention due to its links to microcephaly and, less sensationally, to GBS (Cao-Lormeau et al., <xref ref-type="bibr" rid="B26">2016</xref>). In Ifnar1 knockout mouse spinal cord and dorsal root ganglia-derived cultures (Cumberworth et al., <xref ref-type="bibr" rid="B35">2017</xref>) as well as in a patient who died of Zika-GBS (Dirlikov et al., <xref ref-type="bibr" rid="B40">2018</xref>), PNS neurons and Schwann cells appear rather refractory to infection. However, infection of dorsal root ganglia neurons in Ifnar1 knockout mice in vivo was reported recently (Oh et al., <xref ref-type="bibr" rid="B135">2017</xref>). Differences in the experimental studies may be due to viral strain-specific effects, although dissimilarity in glycosylation of the viral coat protein, related to the cell type in which the virus was propagated pre-administration, is an another confounding factor (Alain Kohl, personal communication). In contrast, CNS glia are highly susceptible in vitro, consistent with white matter pathology in pre-term and newborn infants with congenital Zika virus infection (Chimelli et al., <xref ref-type="bibr" rid="B28">2017</xref>). Whether Zika-GBS has an autoimmune etiology (Uncini et al., <xref ref-type="bibr" rid="B208">2017</xref>) or is due to a direct viral neuropathogenic mechanism remains to be determined.</p>
</boxed-text>
<p>Experimental evidence for inflammation-induced axonal dysfunction came from the widely used animal model of MS, “experimental autoimmune encephalomyelitis” (EAE). EAE is an induced autoimmune reaction against (usually) CNS myelin components, such as myelin oligodendrocyte glycoprotein (MOG). As a tool for understanding axonal injury in human MS, EAE models have important limitations, not least that EAE is a CD4 +ve T cell mediated pathology, whereas the aetiology of MS more likely involves CD8 +ve T cells, though it is still not known and may be heterogeneous in nature (Trapp and Nave, <xref ref-type="bibr" rid="B202">2008</xref>; Stys et al., <xref ref-type="bibr" rid="B192">2012</xref>).</p>
<p>In MOG-induced EAE, Nikic et al. (<xref ref-type="bibr" rid="B133">2011</xref>) demonstrated axonal changes they termed “focal axonal degeneration” (FAD). Using live imaging <italic>in vivo</italic>, they showed that FAD, which begins with focal axonal swelling, either progressed to axonal fragmentation or resolved. Similarly, in a mouse model of Pelizaeus Merzbacher disease (PMD), defined by a primary oligodendropathy, focal axonal swellings can occur on otherwise intact (non-transected) myelinated axons (Edgar et al., <xref ref-type="bibr" rid="B46">2010</xref>; see Mechanisms of injury: axonal pathology downstream of oligodendroglial defects), raising the possibility of a temporal window for therapeutic intervention. FAD can be initiated by high levels of reactive oxygen and reactive nitrogen species (ROS and RNS) alone, implicating macrophages in its evolution in EAE, and likely also in MS, where morphologically similar changes can be observed in acute lesions (Nikic et al., <xref ref-type="bibr" rid="B133">2011</xref>).</p>
<p>This raises the question whether axons undergoing the early pre-fragmentation stage of FAD can support electrical conduction. Certainly, nitric oxide can block neural conduction in rat spinal roots (Redford et al., <xref ref-type="bibr" rid="B159">1997</xref>) and axonal depolarisation and neurological signs correlate with axonal mitochondrial dysfunction and precede demyelination, in mice with MOG EAE (Sadeghian et al., <xref ref-type="bibr" rid="B172">2016</xref>), supporting the suggestion that neuroinflammation <italic>per se</italic> can contribute to neurological dysfunction in MS and other neuroinflammatory disorders. Mechanistically, this is likely related to axonal energy deficits, as nitric oxide and reactive oxygen species can damage mitochondrial respiratory chain complexes (reviewed in Smith and Lassmann, <xref ref-type="bibr" rid="B182">2002</xref>). Indeed, a deficiency in complex IV function in axons (Mahad et al., <xref ref-type="bibr" rid="B113">2009</xref>) and neuronal cell bodies (reviewed in Campbell and Mahad, <xref ref-type="bibr" rid="B25">2018</xref>) in MS has been reported, although the causes and consequences in the disease context are as yet unproven.</p>
<p>Evidence for a role for the adaptive immune system in axonal injury originated from the analysis of mouse models of genetically determined CNS and PNS disorders with secondary immune reactions. Here, a role for T-lymphocytes in secondary axonal injury was demonstrated.by crossbreeding V(D)J recombination activation (<italic>Rag1</italic>) knockout mice, which lack mature T and B lymphocytes, to a model of the leukodystrophy PMD, caused by overexpression of the proteolipid <italic>PLP1</italic> gene (see Mechanisms of injury: axonal pathology downstream of oligodendroglial defects), in which axonal changes were reduced when lymphocytes were depleted. Similar observations were made in heterozygous myelin protein zero <italic>(Mpz)</italic> knockout and homozygous gap junction protein b (<italic>Gjb1</italic>) knockout mice; models of progressive demyelinating forms of the inherited peripheral neuropathies, Charcot Marie Tooth disease (CMT; Kobsar et al., <xref ref-type="bibr" rid="B97">2003</xref> and reviewed in Groh and Martini, <xref ref-type="bibr" rid="B73">2017</xref>). Mechanistically, early localised axonal changes in these mutants seem to be exacerbated by T cells “attacking” the paranodal myelin (reviewed in Groh and Martini, <xref ref-type="bibr" rid="B73">2017</xref>). Nonetheless, immune cells protect myelin and axons in <italic>Mpz</italic> deficient mice, a genetic model of a severe dysmyelinating peripheral neuropathy, Dejerine–Sottas syndrome (DSS; Berghoff et al., <xref ref-type="bibr" rid="B16">2005</xref>). Hence, the role of the adaptive immune system seems to be dependent on disease-specific mechanisms, probably including myelin integrity and the response of the innate immune system (Berghoff et al., <xref ref-type="bibr" rid="B16">2005</xref>).</p>
</sec>
<sec>
<title>Mechanisms of injury: axonal pathology caused by oligodendroglial defects</title>
<p>In humans, mutations in the <italic>PLP1</italic> gene including null, point and duplication/triplication changes, cause allelic leukodystrophies with a broad range of clinical severity, from spastic paraplegia type 2 (SPG2) to the connatal forms of PMD. All of these diseases were first identified by and later successfully modelled in <italic>Plp1</italic> mutant and <italic>Plp1</italic> overexpressing mice (Nave and Griffiths, <xref ref-type="bibr" rid="B129">2004</xref>; Gruenenfelder et al., <xref ref-type="bibr" rid="B74">2011</xref>). PLP and its isoform DM20 are expressed in oligodendrocytes and located in the compact myelin. The view that the survival of myelinated CNS axons is linked to the performance of surrounding glial cells initially emerged from studies of <italic>Plp1</italic> knockout mouse models (Griffiths et al., <xref ref-type="bibr" rid="B72">1998</xref>).</p>
<p>However, defects in myelin biosynthesis and maintenance do not inevitably lead to axonal degeneration. For example, in the spontaneously occurring Long-Evans shaker (<italic>les</italic>) rat and the <italic>shiverer</italic> mouse, which both lack a functional myelin basic protein (<italic>Mbp)</italic> gene (Roach et al., <xref ref-type="bibr" rid="B163">1985</xref>; O'Connor et al., <xref ref-type="bibr" rid="B134">1999</xref>), CNS axons are severely de- or dysmyelinated (Figures <xref ref-type="fig" rid="F4">4A,B</xref>), but degenerative axonal changes are lacking (Rosenbluth, <xref ref-type="bibr" rid="B165">1980</xref>; Griffiths et al., <xref ref-type="bibr" rid="B72">1998</xref>; Edgar et al., <xref ref-type="bibr" rid="B49">2004</xref>; Smith et al., <xref ref-type="bibr" rid="B180">2013</xref>), presumably owing to unimpaired communication between axons and engulfing oligodendroglial processes (summarised in Figure <xref ref-type="fig" rid="F5">5</xref>). Nevertheless, <italic>shiverer</italic> axons do have a reduced calibre and retain an “immature” cytoskeleton (Brady et al., <xref ref-type="bibr" rid="B20">1999</xref>; Kirkpatrick et al., <xref ref-type="bibr" rid="B94">2001</xref>). Thus, <italic>shiverer</italic> elucidates the profound influence the myelinating oligodendrocyte exerts on the axonal cytoskeleton and on radial axonal growth (see Cell autonomous and bi-directional signalling regulate axonal and glial dimensions). Of note, the PNS of <italic>shiverer</italic> mice is fully myelinated (Privat et al., <xref ref-type="bibr" rid="B152">1979</xref>; Kirschner and Ganser, <xref ref-type="bibr" rid="B95">1980</xref>), possibly due to overlapping functions of MBP with myelin protein zero (MPZ) and peripheral myelin protein 2 (PMP2) in peripheral myelin (Martini et al., <xref ref-type="bibr" rid="B115">1995</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<p>Oligodendrocytes support axons. <bold>(A)</bold> In the CNS, oligodendrocytes (green) provide axons with the insulating myelin sheath (green: myelinated internodes). Moreover, oligodendrocytes support axonal integrity and function independent of myelination <italic>per se</italic> (for details see main text). Astrocytes (blue) not only contact blood vessels but additionally interact with axons and oligodendrocytes and contribute to brain homeostasis. Oligodendrocyte precursor cells (not illustrated) are also present in the mature CNS and are the main cellular source for new oligodendrocytes after injury and in remyelination. <bold>(B)</bold> Oligodendrocyte dysfunction leads to a perturbed axon-glia interaction which ultimately impairs axonal health. As the myelinic channel system is likely acting as a route by which oligodendrocytes supply metabolites to the myelinated axons, any perturbation of this system could potentially impact axonal integrity, resulting for example in focal axonal swelling and distal axonal degeneration.</p>
</caption>
<graphic xlink:href="fnins-12-00467-g0005"></graphic>
</fig>
<p>De- and dysmyelination are associated with the (re)distribution of sodium channels along the axolemma, thus maintaining axonal conduction (Utzschneider et al., <xref ref-type="bibr" rid="B209">1993</xref>; Waxman et al., <xref ref-type="bibr" rid="B221">2004</xref>). However, the resultant non-saltatory action potential propagation increases energy consumption, and accordingly, increased numbers of mitochondria have been observed in <italic>shiverer</italic> axons (Andrews et al., <xref ref-type="bibr" rid="B3">2006</xref>) and in human MS tissue (Zambonin et al., <xref ref-type="bibr" rid="B235">2011</xref>).</p>
<p>In contrast to <italic>shiverer</italic>, mice deficient in PLP or CNP (2′,3′-cyclic nucleotide 3′-phosphodiesterase) synthesise normal amounts of myelin, but develop a pronounced axonal pathology (Figures <xref ref-type="fig" rid="F2">2B</xref>, <xref ref-type="fig" rid="F4">4C,D</xref>). Taking advantage of the X-linked nature of the <italic>Plp1</italic> gene and female heterozygotes harbouring a mosaic of wild type and PLP-deficient myelin (the latter with subtle defects in compaction), we demonstrated that secondary axonal changes, such as organelle-filled focal swellings, are localised to the internodes formed by the PLP-deficient myelin (Edgar et al., <xref ref-type="bibr" rid="B49">2004</xref>). This demonstrates that oligodendroglial support of axonal integrity is a very local function. Late onset length-dependent axonal degeneration in this mutant is likely a consequence of these early focal changes and organelle transport stasis (Edgar et al., <xref ref-type="bibr" rid="B49">2004</xref>). That the axonal changes are secondary to the glial-cell defect was confirmed by cell transplantation experiments (Edgar et al., <xref ref-type="bibr" rid="B49">2004</xref>) and using a novel oligodendroglia specific <italic>Plp1</italic> gene knockout model (Lüders et al., <xref ref-type="bibr" rid="B108">2017</xref>). Axon degeneration is also the cause of progressive spasticity in the corresponding human <italic>PLP1</italic> null patients with SPG2 (Garbern et al., <xref ref-type="bibr" rid="B61">2002</xref>); belonging to the family of disorders termed the hereditary spastic paraplegias. In mice, the absence of PLP from myelin causes a secondary loss of SIRT2, a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase, which is normally abundant in myelinic channels (Werner et al., <xref ref-type="bibr" rid="B223">2007</xref>). The function of SIRT2 in myelin is not understood, but as a sensor of the NAD/NADH ratio in the myelin compartment, its activity is likely regulated by oligodendrocyte glycolysis and the generation of lactate.</p>
<p>Similarly, <italic>Cnp1</italic> knockout mice (Lappe-Siefke et al., <xref ref-type="bibr" rid="B102">2003</xref>), lacking a membrane-associated protein of non-compacted myelin, are fully myelinated but focal axonal swellings and degeneration of axons are observed simultaneously, commencing after postnatal day 5 (P5), in all investigated white matter tracts (Edgar et al., <xref ref-type="bibr" rid="B48">2009</xref>). The encoded 2′,3′-cyclic nucleotide phosphodiesterase (CNP) most likely not serving as an enzyme, interacts with actin to antagonise MBP in myelin membrane compaction (Snaidero et al., <xref ref-type="bibr" rid="B185">2017</xref>). Thus, abnormal MBP-dependent closures of the myelinic channels likely result in the observed swellings at the inner tongue, that are predicted to perturb axon-glia communication (Lappe-Siefke et al., <xref ref-type="bibr" rid="B102">2003</xref>; Edgar et al., <xref ref-type="bibr" rid="B48">2009</xref>; Snaidero et al., <xref ref-type="bibr" rid="B185">2017</xref>).</p>
<p>These and other observations have led us to hypothesise that the myelinic channel system is crucial to the function of the oligodendrocyte in axonal support, likely acting as the route through which the oligodendrocyte supplies metabolites to the myelinated axon and delivers membrane proteins to the adaxonal myelin surface (Figure <xref ref-type="fig" rid="F5">5</xref>).</p>
<p>In the <italic>Plp1</italic> transgenic line #72 (Readhead et al., <xref ref-type="bibr" rid="B158">1994</xref>), axonal swellings and axonal transport defects correlate with active demyelination and microglial/macrophage activation in the optic nerve. In contrast, completely demyelinated axons remain intact, suggesting injured myelin and/or neuroinflammation is relatively more detrimental than the absence of myelin <italic>per se</italic> (Edgar et al., <xref ref-type="bibr" rid="B46">2010</xref>). Indeed, axonal injury can occur beneath “not-yet” demyelinated axons in inflammatory demyelinating models (Nikic et al., <xref ref-type="bibr" rid="B133">2011</xref>; Pohl et al., <xref ref-type="bibr" rid="B149">2011</xref>; Oluich et al., <xref ref-type="bibr" rid="B136">2012</xref>). This supports our suggestion that axons shielded from nutrients in the extracellular milieu, are susceptible to injury if even minor damage to myelinic channels leaves oligodendrocytes unable to fuel the axon's energy requirements.</p>
<p>Further evidence for a role of oligodendrocytes in axonal support comes from mice lacking the <italic>Pex5</italic> gene (encoding the peroxisomal biogenesis factor and targeting signal type-I receptor) in myelinating glia. In this model, the absence of oligodendroglial peroxisomes does not interfere with myelination but underlies a progressive clinical phenotype caused by subcortical demyelination, inflammation and widespread axonal degeneration (Kassmann et al., <xref ref-type="bibr" rid="B88">2007</xref>).</p>
<p>Primary oligodendrocyte death also elicits axonal changes. The diphtheria-toxin mediated ablation of oligodendrocytes in mice leads to secondary focal axonal changes and a reduction in axonal densities (Ghosh et al., <xref ref-type="bibr" rid="B65">2011</xref>; Pohl et al., <xref ref-type="bibr" rid="B149">2011</xref>; Oluich et al., <xref ref-type="bibr" rid="B136">2012</xref>). The significant temporal delay between oligodendrocyte cell death and axonal demise can probably be explained by the initial preservation of myelin sheaths, including their content of glycolytic enzymes and metabolite transporters (Saab et al., <xref ref-type="bibr" rid="B171">2016</xref>). Axonal changes in this model are independent of the adaptive immune system, as evidenced by crossbreeding to <italic>Rag1</italic> deficient mice (Pohl et al., <xref ref-type="bibr" rid="B149">2011</xref>), however a late-onset secondary T cell response with fatal demyelination has been reported (Traka et al., <xref ref-type="bibr" rid="B201">2016</xref>).</p>
</sec>
<sec>
<title>Mechanisms of injury: axonal pathology caused by Schwann cell defects</title>
<p>Peripheral neuropathies are a heterogeneous group of diseases and result from inflammatory, toxic and metabolic conditions in addition to genetic defects. The last are referred to as Charcot-Marie-Tooth diseases (CMT) and can be subdivided into forms that primarily affect the Schwann cells (CMT type 1) or the axon (CMT type 2). Evidence for axonal support by Schwann cells emerged from murine mutants and transgenics for the peripheral myelin protein (<italic>Pmp22</italic>) gene (encoding the peripheral myelin protein of 22kDA; PMP22), which model CMT1A. A <italic>Pmp22</italic> point mutation defines the <italic>Trembler</italic> mouse (Suter et al., <xref ref-type="bibr" rid="B196">1992</xref>), which is characterized by hypomyelination, demyelination, reduced axonal calibre, axonal cytoskeletal changes, and alterations in slow axonal transport (De Waegh and Brady, <xref ref-type="bibr" rid="B36">1990</xref>; Kirkpatrick and Brady, <xref ref-type="bibr" rid="B93">1994</xref>). Schwann cell–axon interactions are perturbed at paranodal glial-axonal junctions in <italic>Trembler</italic> (Robertson et al., <xref ref-type="bibr" rid="B164">1997</xref>) and associated with a redistribution of axonal ion channels (Rosenbluth and Bobrowski-Khoury, <xref ref-type="bibr" rid="B167">2014</xref>). Interestingly, nerve graft experiments demonstrated that axonal changes are spatially restricted to segments myelinated by “mutant” Schwann cells (De Waegh et al., <xref ref-type="bibr" rid="B37">1992</xref>). Transgenic overexpression of <italic>Pmp22</italic> also induces dys- and demyelination and, in this case, a slowly progressive, distally pronounced, axonal loss (Sereda et al., <xref ref-type="bibr" rid="B178">1996</xref>; Fledrich et al., <xref ref-type="bibr" rid="B55">2014</xref>), providing a bona fide model of human Charcot-Marie-Tooth disease type 1A (CMT1A). In contrast to PMP22 overexpression in CMT1A disease, a heterozygous deletion of the <italic>PMP22</italic> gene causes hereditary neuropathy with liability to pressure palsies (HNPP) (Nicholson et al., <xref ref-type="bibr" rid="B131">1994</xref>; Adlkofer et al., <xref ref-type="bibr" rid="B1">1995</xref>; Li et al., <xref ref-type="bibr" rid="B105">2007</xref>). HNPP is characterized by focal hypermyelination of peripheral nerves, and the application of mechanical compression induces a conduction block in affected patients as well as in respective animal models (Adlkofer et al., <xref ref-type="bibr" rid="B1">1995</xref>; Li et al., <xref ref-type="bibr" rid="B105">2007</xref>; Bai et al., <xref ref-type="bibr" rid="B9">2010</xref>). Consistent with this, other CMT forms with increased myelin outfoldings, such as CMT4B, demonstrate a reduced nerve conduction velocity as well as a decreased compound muscle action potential (Previtali et al., <xref ref-type="bibr" rid="B151">2007</xref>; Ng et al., <xref ref-type="bibr" rid="B130">2013</xref>). However, the precise molecular mechanisms of disease progression and functional failure in CMT diseases remain only partially understood, and it is most likely that all human dysmyelinating neuropathies share a defect of Schwann cell-axon communication that is ultimately responsible for axonal conduction blocks, degeneration and a progressive clinical phenotype (Nave et al., <xref ref-type="bibr" rid="B128">2007</xref>).</p>
<p>The role of the “mutant” glial cell versus altered myelin in PMP22-related axonal changes could not be uncoupled in these demyelinating models. Rather, it was the observation that axonal changes occur on axons with relatively (<italic>Mag</italic> and <italic>Plp1</italic> knockout mice) or completely (<italic>Cnp1</italic> knockout mice) normal-appearing compact myelin that provided evidence that glial cells, independent of myelin, support axonal health (Nave, <xref ref-type="bibr" rid="B125">2010a</xref>; and see Mechanisms of injury: axonal pathology caused by oligodenroglial defects). Mice lacking the myelin-associated glycoprotein (<italic>Mag</italic>) gene, assemble CNS and PNS myelin that harbours very minor morphological changes at the inner wrap, but have reduced axon calibre associated with altered neurofilament spacing and phosphorylation in the PNS (Yin et al., <xref ref-type="bibr" rid="B231">1998</xref>; Pan et al., <xref ref-type="bibr" rid="B138">2005</xref>). A progressive degenerative response including paranodal myelin tomaculi and axonal loss subsequently ensues (Yin et al., <xref ref-type="bibr" rid="B231">1998</xref>; Pan et al., <xref ref-type="bibr" rid="B138">2005</xref>).</p>
<p>Just as oligodendrocytes likely provide metabolic support for axons (see Energy supply and use), so there is evidence that Schwann cells play a similar role in the PNS. Beirowski et al. (<xref ref-type="bibr" rid="B15">2014</xref>) demonstrated that knocking out the gene encoding the ubiquitously expressed liver kinase B1 (LKB1), specifically in adult Schwann cells, did not affect myelin morphology but led to axonal loss, most specifically of small sensory axons in Remak bundles (C fibres). LKB1 is a key regulator of energy homeostasis, suggesting axonal degeneration in this model could pertain to axonal energy insufficiency; however the phenotype is complex and its interpretation is not straightforward. More recently, using mice lacking the nutrient sensing protein O-GlcNAc transferase (OGT) in Schwann cells, the same group demonstrated that Schwann cell OGT is required for the maintenance of normal myelin and to prevent axonal loss (Kim et al., <xref ref-type="bibr" rid="B91">2016</xref>). Notably, mice lacking the myelin protein Periaxin (a model for DSS), which is O-GlcNAcyated, develop a very similar phenotype (Gillespie et al., <xref ref-type="bibr" rid="B66">2000</xref>; Court et al., <xref ref-type="bibr" rid="B34">2004</xref>) to the conditional OGT knockout mice (Kim et al., <xref ref-type="bibr" rid="B91">2016</xref>). Recently, using the compound action potential as a readout of <italic>ex-vivo</italic> sciatic nerve function, Rich and Brown (<xref ref-type="bibr" rid="B161">2018</xref>) provided evidence that non-myelinated C fibres and myelinated A fibres in the same sciatic nerve preparation, have distinct metabolic profiles. The authors showed that when fructose is supplied as the sole energy source, C fibres can utilise it directly whereas A fibres benefit through receipt of lactate from Schwann cells. Together, these data are compatible with the hypothesis that myelinating cells provide metabolic support to axons encased in compact myelin, to abrogate the consequences of their being sequestered from extracellular glucose (Nave, <xref ref-type="bibr" rid="B126">2010b</xref>).</p>
</sec>
</sec>
<sec id="s5">
<title>Conclusions and implications for human diseases</title>
<p>In summary, we have provided an overview of the unique physical and functional properties of (myelinated) axons, with an emphasis on how these might contribute to the axon's vulnerability to injury in a variety of diseases and traumas. In particular, its relative isolation (in terms of distance) from its cell body, dependence on long-distance axonal transport, and high energy demands resulting largely from “spiking”, probably all render axons susceptible to injury from a variety of insults.</p>
<p>In some cases, such as SPG10, which is due to a mutation in <italic>KIF5A</italic> (encoding a motor protein of axonal transport), the reason why axons are vulnerable seems evident. However, the particular susceptibility of motor neuron axons in some complex disorders such as familial amyotrophic lateral sclerosis (fALS), in which the mutated gene (<italic>SOD1</italic>; superoxide dismutase 1) is expressed in all neural cell types, remains an enigma; although multiple mechanisms have been implicated.</p>
<p>In MS, a “high grade” inflammatory demyelinating disorder, axonal injury probably also entails multiple mechanisms (see Mechanisms of injury: Focal axonal degeneration and inflammation-induced axonal dysfunction) and many aspects remain poorly understood, including the direct role for lymphocytes themselves. In classical axonal and demyelinating GBS, which also fall into this category, antibody-mediated complement activation and downstream calpain-dependent proteolysis is now generally considered the most likely effector of axonal demise (Willison et al., <xref ref-type="bibr" rid="B224">2016</xref>). In the “low grade” inflammatory disorder AMN, axonal degeneration happens in a length dependent fashion (Box <xref ref-type="boxed-text" rid="Box2">2</xref>), but as in fALS, the mutated <italic>ABCD1</italic> gene is expressed in virtually all cell types and the underlying reasons for the axonal phenotype remain poorly understood. Insight into the effectors of this and other genetically-determined length-dependent axonopathies might come from understanding how axons are injured in the neurotoxic disorders like OPIDN (Box <xref ref-type="boxed-text" rid="Box1">1</xref>). With respect to axonopathies secondary to mutations in genes whose products are expressed in oligodendrocytes and/or Schwann cells, there is increasing evidence that axonal degeneration reflects a failure of the myelinating cell to provide metabolic support to the axon. Indeed axonal energy insufficiency might represent a common pathway in multiple neurodegenerative disorders; either due to failure of metabolic support from neighbouring glia; to ischemia as in stroke; or as a consequence of failure of OXPHOS due to nitric oxide (and potentially other factors) mediated injury to axonal mitochondria (summarised in Figure <xref ref-type="fig" rid="F5">5B</xref>).</p>
<p>Intriguingly, in rat and mouse models of axonopathies, the obvious restriction imposed on the physical length of axons compared to humans and larger species, does not reduce their susceptibility to “length-dependent degeneration”, as for example in mouse models of SPG2 and CMT. Thus, actual physical length is not the defining factor. Rather, length-dependent degeneration in rodents is compatible with energy insufficiency being causally related to axonal demise, because presumably, energy provision is proportionally less in these small species, rendering their “long” axons just as susceptible as in larger species consuming a much greater calorie load.</p>
<p>Finally, axonal degeneration and/or dysfunction might not be the only axonally-related factors that contribute to neurological symptoms. Recently, we and others demonstrated reduced axonal calibre in mouse models of two complex neuropsychological disorders (Rett and Angelman syndromes; Box <xref ref-type="boxed-text" rid="Box5">5</xref>), which could potentially contribute to symptoms. Thus a variety of axonal changes, from reduced calibre, through mitochondrial dysfunction and focal swelling to transection, can probably all contribute to neurological symptoms in neurodegenerative diseases or injuries with primary or secondary involvement of axons.</p>
<boxed-text id="Box5" position="float">
<label>Box 5</label>
<caption>
<title><bold>Rett and Angelman syndromes</bold>.</title>
</caption>
<p>Rett and Angelman syndromes comprise part of the spectrum of neurologic disorders previously considered associated with autism (Jedele, <xref ref-type="bibr" rid="B83">2007</xref>). Both present, after a short period of normal development, with global developmental delay, severe speech and communication deficits, progressive microcephaly, seizures, autistic behavior and a characteristic movement disorder. Angelman syndrome is due to loss of function of the maternally inherited ubiquitin protein ligase E3A (UBE3A) allele, while Rett syndrome is due in the majority of cases to loss of function mutation in the X-linked methyl-CpG- binding protein 2 (MECP2) gene. Remarkably, clinical features occur in the absence of evident neurodegeneration, and activation of a silenced Mecp2 allele, even with a radically truncated MeCP2 protein, in adult mice reverses neurological and morphological changes, suggesting MeCP2 might be required for maintenance of neuronal function, rather than for normal development (Guy et al., <xref ref-type="bibr" rid="B75">2007</xref>; Tillotson et al., <xref ref-type="bibr" rid="B199">2017</xref>). Female mice heterozygous for a Mecp2 null allele develop normally but subsequently exhibit a stiff, uncoordinated gait, tremor, breathing difficulties and hindlimb clasping. Although there is no evidence of axonal degeneration in the PNS of adult <italic>Mecp2</italic><sup>+/−</sup> mice, the mean diameter of sciatic nerve axons is significantly reduced and myelin is slightly thinner than normal (Bahey et al., <xref ref-type="bibr" rid="B8">2017</xref>). Similarly, in a mouse model of Angelman syndrome, reduced axonal diameter and white matter abnormalities underlie impaired brain growth and microcephaly (Judson et al., <xref ref-type="bibr" rid="B84">2017</xref>). Similar subtle morphological changes could, in principle, contribute to the neurological signs in Rett and Angelman syndromes.</p>
</boxed-text>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>JE and RS wrote the review and provided images. JE planned and edited the review. K-AN was involved in planning, writing and finally edited the manuscript. WM contributed electron micrographs and figure legends.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>The authors thank Dr Stuart Cobb and Professors David Attwell and Michael Coleman for helpful discussion. Work in our labs is funded by the Multiple Sclerosis Society UK (Ref 038) and European Union's Horizon 2020 research and innovation programme under ZikaPLAN grant agreement No 734584 (JE); DFG (SPP 1757) and the European Research Council (MyeliNANO) (K-AN); ERA-NET for Research Programs on Rare Diseases E-RARE-3 (01GM1605) and the German network on Charcot-Marie-Tooth Disease (CMT-NET, 01GM1511C) (RS).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adlkofer</surname><given-names>K.</given-names></name><name><surname>Martini</surname><given-names>R.</given-names></name><name><surname>Aguzzi</surname><given-names>A.</given-names></name><name><surname>Zielasek</surname><given-names>J.</given-names></name><name><surname>Toyka</surname><given-names>K. V.</given-names></name><name><surname>Suter</surname><given-names>U.</given-names></name></person-group> (<year>1995</year>). <article-title>Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice</article-title>. <source/>Nat. Genet.
<volume>11</volume>, <fpage>274</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1038/ng1195-274</pub-id><pub-id pub-id-type="pmid">7581450</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>R. G.</given-names></name><name><surname>Lyons</surname><given-names>D. A.</given-names></name></person-group> (<year>2017</year>). <article-title>On myelinated axon plasticity and neuronal circuit formation and function</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>10023</fpage>–<lpage>10034</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3185-16.2017</pub-id><pub-id pub-id-type="pmid">29046438</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>H. E.</given-names></name><name><surname>White</surname><given-names>K.</given-names></name><name><surname>Thomson</surname><given-names>C. E.</given-names></name><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>Bates</surname><given-names>D.</given-names></name><name><surname>Griffiths</surname><given-names>I. R.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the shiverer mouse</article-title>. <source/>J. Neurosci. Res.
<volume>83</volume>, <fpage>1533</fpage>–<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.20842</pub-id><pub-id pub-id-type="pmid">16555298</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>Ford</surname><given-names>M. C.</given-names></name><name><surname>Cossell</surname><given-names>L.</given-names></name><name><surname>Ishida</surname><given-names>K.</given-names></name><name><surname>Tohyama</surname><given-names>K.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Node of Ranvier length as a potential regulator of myelinated axon conduction speed</article-title>. <source/>Elife
<volume>6</volume>:<fpage>e23329</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.23329</pub-id><pub-id pub-id-type="pmid">28130923</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur-Farraj</surname><given-names>P. J.</given-names></name><name><surname>Latouche</surname><given-names>M.</given-names></name><name><surname>Wilton</surname><given-names>D. K.</given-names></name><name><surname>Quintes</surname><given-names>S.</given-names></name><name><surname>Chabrol</surname><given-names>E.</given-names></name><name><surname>Banerjee</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration</article-title>. <source/>Neuron
<volume>75</volume>, <fpage>633</fpage>–<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.06.021</pub-id><pub-id pub-id-type="pmid">22920255</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attwell</surname><given-names>D.</given-names></name><name><surname>Laughlin</surname><given-names>S. B.</given-names></name></person-group> (<year>2001</year>). <article-title>An energy budget for signaling in the grey matter of the brain</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>21</volume>, <fpage>1133</fpage>–<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1097/00004647-200110000-00001</pub-id><pub-id pub-id-type="pmid">11598490</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avery</surname><given-names>M. A.</given-names></name><name><surname>Sheehan</surname><given-names>A. E.</given-names></name><name><surname>Kerr</surname><given-names>K. S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Freeman</surname><given-names>M. R.</given-names></name></person-group> (<year>2009</year>). <article-title>WldS requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration</article-title>. <source/>J. Cell Biol.
<volume>184</volume>, <fpage>501</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200808042</pub-id><pub-id pub-id-type="pmid">19237597</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahey</surname><given-names>N. G.</given-names></name><name><surname>Gadalla</surname><given-names>K. K. E.</given-names></name><name><surname>McGonigal</surname><given-names>R.</given-names></name><name><surname>Bailey</surname><given-names>M. E. S.</given-names></name><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>Cobb</surname><given-names>S. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Reduced axonal diameter of peripheral nerve fibers in a mouse model of Rett syndrome</article-title>. <source/>Neuroscience
<volume>358</volume>, <fpage>261</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.06.061</pub-id><pub-id pub-id-type="pmid">28687309</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Katona</surname><given-names>I.</given-names></name><name><surname>Saporta</surname><given-names>M. A.</given-names></name><name><surname>Shy</surname><given-names>M. E.</given-names></name><name><surname>O'Malley</surname><given-names>H. A.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Conduction block in PMP22 deficiency</article-title>. <source/>J Neurosci. <volume>30</volume>, <fpage>600</fpage>–<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4264-09.2010</pub-id><pub-id pub-id-type="pmid">20071523</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baraban</surname><given-names>M.</given-names></name><name><surname>Koudelka</surname><given-names>S.</given-names></name><name><surname>Lyons</surname><given-names>D. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Ca (2+) activity signatures of myelin sheath formation and growth <italic>in vivo</italic></article-title>. <source/>Nat. Neurosci.
<volume>21</volume>, <fpage>19</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-017-0040-x</pub-id><pub-id pub-id-type="pmid">29230058</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>L. F.</given-names></name><name><surname>Weber</surname><given-names>B.</given-names></name></person-group> (<year>2018</year>). <article-title>CrossTalk proposal: an important astrocyte-to-neuron lactate shuttle couples neuronal activity to glucose utilisation in the brain</article-title>. <source/>J. Physiol.
<volume>596</volume>, <fpage>347</fpage>–<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1113/JP274944</pub-id><pub-id pub-id-type="pmid">29292516</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>N. G.</given-names></name><name><surname>Richter-Landsberg</surname><given-names>C.</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Role of the oligodendroglial cytoskeleton in differentiation and myelination</article-title>. <source/>Glia
<volume>57</volume>, <fpage>1691</fpage>–<lpage>1705</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20885</pub-id><pub-id pub-id-type="pmid">19455583</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bechler</surname><given-names>M. E.</given-names></name><name><surname>Byrne</surname><given-names>L.</given-names></name><name><surname>ffrench-Constant</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>CNS myelin sheath lengths are an intrinsic property of oligodendrocytes</article-title>. <source/>Curr. Biol.
<volume>25</volume>, <fpage>2411</fpage>–<lpage>2416</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2015.07.056</pub-id><pub-id pub-id-type="pmid">26320951</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bechler</surname><given-names>M. E.</given-names></name><name><surname>Swire</surname><given-names>M.</given-names></name><name><surname>ffrench-Constant</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Intrinsic and adaptive myelination-A sequential mechanism for smart wiring in the brain</article-title>. <source/>Dev. Neurobiol.
<volume>78</volume>, <fpage>68</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22518</pub-id><pub-id pub-id-type="pmid">28834358</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beirowski</surname><given-names>B.</given-names></name><name><surname>Babetto</surname><given-names>E.</given-names></name><name><surname>Golden</surname><given-names>J. P.</given-names></name><name><surname>Chen</surname><given-names>Y. J.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Gross</surname><given-names>R. W.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>1351</fpage>–<lpage>1361</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3809</pub-id><pub-id pub-id-type="pmid">25195104</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berghoff</surname><given-names>M.</given-names></name><name><surname>Samsam</surname><given-names>M.</given-names></name><name><surname>Muller</surname><given-names>M.</given-names></name><name><surname>Kobsar</surname><given-names>I.</given-names></name><name><surname>Toyka</surname><given-names>K. V.</given-names></name><name><surname>Kiefer</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene</article-title>. <source/>Mol. Cell. Neurosci.
<volume>28</volume>, <fpage>118</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2004.09.001</pub-id><pub-id pub-id-type="pmid">15607947</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beuche</surname><given-names>W.</given-names></name><name><surname>Friede</surname><given-names>R. L.</given-names></name></person-group> (<year>1984</year>). <article-title>The role of non-resident cells in Wallerian degeneration</article-title>. <source/>J. Neurocytol.
<volume>13</volume>, <fpage>767</fpage>–<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1007/BF01148493</pub-id><pub-id pub-id-type="pmid">6512566</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bomont</surname><given-names>P.</given-names></name><name><surname>Cavalier</surname><given-names>L.</given-names></name><name><surname>Blondeau</surname><given-names>F.</given-names></name><name><surname>Ben Hamida</surname><given-names>C.</given-names></name><name><surname>Belal</surname><given-names>S.</given-names></name><name><surname>Tazir</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy</article-title>. <source/>Nat. Genet.
<volume>26</volume>, <fpage>370</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1038/81701</pub-id><pub-id pub-id-type="pmid">11062483</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boullerne</surname><given-names>A. I.</given-names></name></person-group> (<year>2016</year>). <article-title>The history of myelin</article-title>. <source/>Exp. Neurol.
<volume>283</volume>, <fpage>431</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.06.005</pub-id><pub-id pub-id-type="pmid">27288241</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>S. T.</given-names></name><name><surname>Witt</surname><given-names>A. S.</given-names></name><name><surname>Kirkpatrick</surname><given-names>L. L.</given-names></name><name><surname>De Waegh</surname><given-names>S. M.</given-names></name><name><surname>Readhead</surname><given-names>C.</given-names></name><name><surname>Tu</surname><given-names>P. H.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Formation of compact myelin is required for maturation of the axonal cytoskeleton</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>7278</fpage>–<lpage>7288</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-17-07278.1999</pub-id><pub-id pub-id-type="pmid">10460234</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brauckmann</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>The virtue of being too early: Paul A. Weiss, and ‘axonal transport’</article-title>. <source/>Hist. Philos. Life Sci.
<volume>26</volume>, <fpage>333</fpage>–<lpage>353</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.jstor.org/stable/23333720">https://www.jstor.org/stable/23333720</ext-link><pub-id pub-id-type="pmid">16302692</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bristow</surname><given-names>E. A.</given-names></name><name><surname>Griffiths</surname><given-names>P. G.</given-names></name><name><surname>Andrews</surname><given-names>R. M.</given-names></name><name><surname>Johnson</surname><given-names>M. A.</given-names></name><name><surname>Turnbull</surname><given-names>D. M.</given-names></name></person-group> (<year>2002</year>). <article-title>The distribution of mitochondrial activity in relation to optic nerve structure</article-title>. <source/>Arch. Ophthalmol.
<volume>120</volume>, <fpage>791</fpage>–<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1001/archopht.120.6.791</pub-id><pub-id pub-id-type="pmid">12049585</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A. M.</given-names></name><name><surname>Wender</surname><given-names>R.</given-names></name><name><surname>Ransom</surname><given-names>B. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Metabolic substrates other than glucose support axon function in central white matter</article-title>. <source/>J. Neurosci. Res.
<volume>66</volume>, <fpage>839</fpage>–<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10081</pub-id><pub-id pub-id-type="pmid">11746409</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buser</surname><given-names>A. M.</given-names></name><name><surname>Erne</surname><given-names>B.</given-names></name><name><surname>Werner</surname><given-names>H. B.</given-names></name><name><surname>Nave</surname><given-names>K. A.</given-names></name><name><surname>Schaeren-Wiemers</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>The septin cytoskeleton in myelinating glia</article-title>. <source/>Mol. Cell. Neurosci.
<volume>40</volume>, <fpage>156</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2008.10.002</pub-id><pub-id pub-id-type="pmid">19026747</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>G.</given-names></name><name><surname>Mahad</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis</article-title>. <source/>FEBS Lett.
<volume>17</volume>:<fpage>1873</fpage>–<lpage>3468</lpage>
<pub-id pub-id-type="doi">10.1002/1873-3468.13013</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao-Lormeau</surname><given-names>V. M.</given-names></name><name><surname>Blake</surname><given-names>A.</given-names></name><name><surname>Mons</surname><given-names>S.</given-names></name><name><surname>Lastere</surname><given-names>S.</given-names></name><name><surname>Roche</surname><given-names>C.</given-names></name><name><surname>Vanhomwegen</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study</article-title>. <source/>Lancet
<volume>9</volume>, <fpage>1531</fpage>–<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00562-6</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charles</surname><given-names>P.</given-names></name><name><surname>Tait</surname><given-names>S.</given-names></name><name><surname>Faivre-Sarrailh</surname><given-names>C.</given-names></name><name><surname>Barbin</surname><given-names>G.</given-names></name><name><surname>Gunn-Moore</surname><given-names>F.</given-names></name><name><surname>Denisenko-Nehrbass</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction</article-title>. <source/>Curr. Biol.
<volume>12</volume>, <fpage>217</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-9822(01)00680-7</pub-id><pub-id pub-id-type="pmid">11839274</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimelli</surname><given-names>L.</given-names></name><name><surname>Melo</surname><given-names>A. S. O.</given-names></name><name><surname>Avvad-Portari</surname><given-names>E.</given-names></name><name><surname>Wiley</surname><given-names>C. A.</given-names></name><name><surname>Camacho</surname><given-names>A. H. S.</given-names></name><name><surname>Lopes</surname><given-names>V. S.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>The spectrum of neuropathological changes associated with congenital Zika virus infection</article-title>. <source/>Acta Neuropathol.
<volume>133</volume>, <fpage>983</fpage>–<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-017-1699-5</pub-id><pub-id pub-id-type="pmid">28332092</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Axon degeneration mechanisms: commonality amid diversity</article-title>. <source/>Nat. Rev. Neurosci.
<volume>6</volume>, <fpage>889</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1788</pub-id><pub-id pub-id-type="pmid">16224497</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>M. P.</given-names></name><name><surname>Conforti</surname><given-names>L.</given-names></name><name><surname>Buckmaster</surname><given-names>E. A.</given-names></name><name><surname>Tarlton</surname><given-names>A.</given-names></name><name><surname>Ewing</surname><given-names>R. M.</given-names></name><name><surname>Brown</surname><given-names>M. C.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>An 85-kb tandem triplication in the slow Wallerian degeneration (<italic>Wld</italic><sup>s</sup>) mouse</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>95</volume>, <fpage>9985</fpage>–<lpage>9990</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.17.9985</pub-id><pub-id pub-id-type="pmid">9707587</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conforti</surname><given-names>L.</given-names></name><name><surname>Gilley</surname><given-names>J.</given-names></name><name><surname>Coleman</surname><given-names>M. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Wallerian degeneration: an emerging axon death pathway linking injury and disease</article-title>. <source/>Nat. Rev. Neurosci.
<volume>15</volume>, <fpage>394</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3680</pub-id><pub-id pub-id-type="pmid">24840802</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conforti</surname><given-names>L.</given-names></name><name><surname>Wilbrey</surname><given-names>A.</given-names></name><name><surname>Morreale</surname><given-names>G.</given-names></name><name><surname>Janeckova</surname><given-names>L.</given-names></name><name><surname>Beirowski</surname><given-names>B.</given-names></name><name><surname>Adalbert</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>WldS protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice</article-title>. <source/>J. Cell Biol.
<volume>184</volume>, <fpage>491</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200807175</pub-id><pub-id pub-id-type="pmid">19237596</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Court</surname><given-names>F. A.</given-names></name><name><surname>Midha</surname><given-names>R.</given-names></name><name><surname>Cisterna</surname><given-names>B. A.</given-names></name><name><surname>Grochmal</surname><given-names>J.</given-names></name><name><surname>Shakhbazau</surname><given-names>A.</given-names></name><name><surname>Hendriks</surname><given-names>W. T.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Morphological evidence for a transport of ribosomes from Schwann cells to regenerating axons</article-title>. <source/>Glia
<volume>59</volume>, <fpage>1529</fpage>–<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1002/glia.21196</pub-id><pub-id pub-id-type="pmid">21656857</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Court</surname><given-names>F. A.</given-names></name><name><surname>Sherman</surname><given-names>D. L.</given-names></name><name><surname>Pratt</surname><given-names>T.</given-names></name><name><surname>Garry</surname><given-names>E. M.</given-names></name><name><surname>Ribchester</surname><given-names>R. R.</given-names></name><name><surname>Cottrell</surname><given-names>D. F.</given-names></name><name><surname>Fleetwood-Walker</surname><given-names>S. M.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves</article-title>. <source/>Nature
<volume>431</volume>, <fpage>191</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1038/nature02841</pub-id><pub-id pub-id-type="pmid">15356632</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cumberworth</surname><given-names>S. L.</given-names></name><name><surname>Barrie</surname><given-names>J. A.</given-names></name><name><surname>Cunningham</surname><given-names>M. E.</given-names></name><name><surname>de Figueiredo</surname><given-names>D. P. G.</given-names></name><name><surname>Schultz</surname><given-names>V.</given-names></name><name><surname>Wilder-Smith</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected</article-title>. <source/>Acta Neuropathol. Commun.
<volume>5</volume>:<fpage>50</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-017-0450-8</pub-id><pub-id pub-id-type="pmid">28645311</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Waegh</surname><given-names>S. M.</given-names></name><name><surname>Brady</surname><given-names>S. T.</given-names></name></person-group> (<year>1990</year>). <article-title>Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an <italic>in vivo</italic> model for Schwann cell-axon interactions</article-title>. <source/>J. Neurosci.
<volume>10</volume>, <fpage>1855</fpage>–<lpage>1865</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.10-06-01855.1990</pub-id><pub-id pub-id-type="pmid">2355253</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Waegh</surname><given-names>S. M.</given-names></name><name><surname>Lee</surname><given-names>V. M. Y.</given-names></name><name><surname>Brady</surname><given-names>S. T.</given-names></name></person-group> (<year>1992</year>). <article-title>Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells</article-title>. <source/>Cell
<volume>68</volume>, <fpage>451</fpage>–<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(92)90183-D</pub-id><pub-id pub-id-type="pmid">1371237</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>S. M.</given-names></name><name><surname>Loreto</surname><given-names>A.</given-names></name><name><surname>Orsomando</surname><given-names>G.</given-names></name><name><surname>Mori</surname><given-names>V.</given-names></name><name><surname>Zamporlini</surname><given-names>F.</given-names></name><name><surname>Hulse</surname><given-names>R. P.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>NMN Deamidase delays wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency <italic>in vivo</italic></article-title>. <source/>Curr. Biol.
<volume>27</volume>, <fpage>784</fpage>–<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2017.01.070</pub-id><pub-id pub-id-type="pmid">28262487</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>S. M.</given-names></name><name><surname>Nascimento-Ferreira</surname><given-names>I.</given-names></name><name><surname>Orsomando</surname><given-names>G</given-names></name><name><surname>Mori</surname><given-names>V</given-names></name><name><surname>Gilley</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration</article-title>. <source/>Cell Death Differ.
<volume>22</volume>, <fpage>731</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2014.164</pub-id><pub-id pub-id-type="pmid">25323584</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirlikov</surname><given-names>E.</given-names></name><name><surname>Torres</surname><given-names>J. V.</given-names></name><name><surname>Martines</surname><given-names>R. B.</given-names></name><name><surname>Reagan-Steiner</surname><given-names>S.</given-names></name><name><surname>Perez</surname><given-names>G. V.</given-names></name><name><surname>Rivera</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Postmortem Findings in Patient with Guillain-Barre Syndrome and Zika Virus Infection</article-title>. <source/>Emerging Infect. Dis.
<volume>24</volume>, <fpage>114</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.3201/eid2401.171331</pub-id><pub-id pub-id-type="pmid">29261094</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domenech-Estevez</surname><given-names>E.</given-names></name><name><surname>Baloui</surname><given-names>H.</given-names></name><name><surname>Repond</surname><given-names>C.</given-names></name><name><surname>Rosafio</surname><given-names>K.</given-names></name><name><surname>Medard</surname><given-names>J. J.</given-names></name><name><surname>Tricaud</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Distribution of monocarboxylate transporters in the peripheral nervous system suggests putative roles in lactate shuttling and myelination</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>4151</fpage>–<lpage>4156</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3534-14.2015</pub-id><pub-id pub-id-type="pmid">25762662</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>H. H.</given-names></name><name><surname>Hoke</surname><given-names>G. W.</given-names></name></person-group> (<year>1905</year>). <article-title>On the areas of the axis cylinder and medullary sheath as seen in cross sections of the spinal nerves of vertebrates</article-title>. <source/>J. Comp. Neurol.
<volume>15</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1002/cne.920150102</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumenieu</surname><given-names>M.</given-names></name><name><surname>Oule</surname><given-names>M.</given-names></name><name><surname>Kreutz</surname><given-names>M. R.</given-names></name><name><surname>Lopez-Rojas</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>The segregated expression of voltage-gated potassium and sodium channels in neuronal membranes: functional implications and regulatory mechanisms</article-title>. <source/>Front. Cell. Neurosci.
<volume>11</volume>:<fpage>115</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00115</pub-id><pub-id pub-id-type="pmid">28484374</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Economo</surname><given-names>M. N.</given-names></name><name><surname>Clack</surname><given-names>N. G.</given-names></name><name><surname>Lavis</surname><given-names>L. D.</given-names></name><name><surname>Gerfen</surname><given-names>C. R.</given-names></name><name><surname>Svoboda</surname><given-names>K.</given-names></name><name><surname>Myers</surname><given-names>E. W.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>A platform for brain-wide imaging and reconstruction of individual neurons</article-title>. <source/>Elife
<volume>5</volume>:<fpage>e10566</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.10566</pub-id><pub-id pub-id-type="pmid">26796534</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>Griffiths</surname><given-names>I. R.</given-names></name></person-group> (<year>2013</year>). <article-title>White matter structure: a microscopist's view</article-title>, in <source/>Diffusion MRI, eds <person-group person-group-type="editor"><name><surname>Johansen-Berg</surname><given-names>H.</given-names></name><name><surname>Behrens</surname><given-names>T. E. J.</given-names></name></person-group> (<publisher-loc>London</publisher-loc>: <publisher-name>Elsevier</publisher-name>), <fpage>127</fpage>–<lpage>149</lpage>.</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>McCulloch</surname><given-names>M. C.</given-names></name><name><surname>Montague</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>A. M.</given-names></name><name><surname>Thilemann</surname><given-names>S.</given-names></name><name><surname>Pratola</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease</article-title>. <source/>EMBO Mol. Med.
<volume>2</volume>, <fpage>42</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.200900057</pub-id><pub-id pub-id-type="pmid">20091761</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>McCulloch</surname><given-names>M. C.</given-names></name><name><surname>Thomson</surname><given-names>C. E.</given-names></name><name><surname>Griffiths</surname><given-names>I. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Distribution of mitochondria along small-diameter myelinated central nervous system axons</article-title>. <source/>J. Neurosci. Res.
<volume>86</volume>, <fpage>2250</fpage>–<lpage>2257</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.21672</pub-id><pub-id pub-id-type="pmid">18381760</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>McLaughlin</surname><given-names>M.</given-names></name><name><surname>Werner</surname><given-names>H. B.</given-names></name><name><surname>McCulloch</surname><given-names>M. C.</given-names></name><name><surname>Barrie</surname><given-names>J. A.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1</article-title>. <source/>Glia
<volume>57</volume>, <fpage>1815</fpage>–<lpage>1824</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20893</pub-id><pub-id pub-id-type="pmid">19459211</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>McLaughlin</surname><given-names>M.</given-names></name><name><surname>Yool</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>S. C.</given-names></name><name><surname>Fowler</surname><given-names>J.</given-names></name><name><surname>Montague</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia</article-title>. <source/>J. Cell Biol.
<volume>166</volume>, <fpage>121</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200312012</pub-id><pub-id pub-id-type="pmid">15226307</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emery</surname><given-names>B.</given-names></name><name><surname>Lu</surname><given-names>Q. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Transcriptional and epigenetic regulation of oligodendrocyte development and myelination in the central nervous system</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>7</volume>:<fpage>a020461</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a020461</pub-id><pub-id pub-id-type="pmid">26134004</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engl</surname><given-names>E.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Non-signalling energy use in the brain</article-title>. <source/>J. Physiol. (Lond).
<volume>593</volume>, <fpage>3417</fpage>–<lpage>3429</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2014.282517</pub-id><pub-id pub-id-type="pmid">25639777</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engl</surname><given-names>E.</given-names></name><name><surname>Jolivet</surname><given-names>R.</given-names></name><name><surname>Hall</surname><given-names>C. N.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Non-signalling energy use in the developing rat brain</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>37</volume>, <fpage>951</fpage>–<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X16648710</pub-id><pub-id pub-id-type="pmid">27170699</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essuman</surname><given-names>K.</given-names></name><name><surname>Summers</surname><given-names>D. W.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>DiAntonio</surname><given-names>A.</given-names></name><name><surname>Milbrandt</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration</article-title>. <source/>Neuron
<volume>93</volume>, <fpage>1334</fpage>–<lpage>1343</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.022</pub-id><pub-id pub-id-type="pmid">28334607</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernando</surname><given-names>R. N.</given-names></name><name><surname>Cotter</surname><given-names>L.</given-names></name><name><surname>Perrin-Tricaud</surname><given-names>C.</given-names></name><name><surname>Berthelot</surname><given-names>J.</given-names></name><name><surname>Bartolami</surname><given-names>S.</given-names></name><name><surname>Pereira</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>12186</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms12186</pub-id><pub-id pub-id-type="pmid">27435623</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fledrich</surname><given-names>R.</given-names></name><name><surname>Stassart</surname><given-names>R. M.</given-names></name><name><surname>Klink</surname><given-names>A.</given-names></name><name><surname>Rasch</surname><given-names>L. M.</given-names></name><name><surname>Prukop</surname><given-names>T.</given-names></name><name><surname>Haag</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A</article-title>. <source/>Nat. Med.
<volume>20</volume>, <fpage>1055</fpage>–<lpage>1061</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3664</pub-id><pub-id pub-id-type="pmid">25150498</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>R. J.</given-names></name><name><surname>ffrench-Constant</surname><given-names>C.</given-names></name><name><surname>Edgar</surname><given-names>J. M.</given-names></name><name><surname>Smith</surname><given-names>K. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Neuroprotection and repair in multiple sclerosis</article-title>. <source/>Nat. Rev. Neurol.
<volume>8</volume>, <fpage>624</fpage>–<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2012.200</pub-id><pub-id pub-id-type="pmid">23026979</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franssen</surname><given-names>E. H.</given-names></name><name><surname>Zhao</surname><given-names>R. R.</given-names></name><name><surname>Koseki</surname><given-names>H.</given-names></name><name><surname>Kanamarlapudi</surname><given-names>V.</given-names></name><name><surname>Hoogenraad</surname><given-names>C. C.</given-names></name><name><surname>Eva</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Exclusion of integrins from CNS axons is regulated by Arf6 activation and the AIS</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>8359</fpage>–<lpage>8375</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2850-14.2015</pub-id><pub-id pub-id-type="pmid">26019348</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>M. M.</given-names></name><name><surname>Holzbaur</surname><given-names>E. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Integrated regulation of motor-driven organelle transport by scaffolding proteins</article-title>. <source/>Trends Cell Biol.
<volume>24</volume>, <fpage>564</fpage>–<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2014.05.002</pub-id><pub-id pub-id-type="pmid">24953741</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukui</surname><given-names>H.</given-names></name><name><surname>Diaz</surname><given-names>F.</given-names></name><name><surname>Garcia</surname><given-names>S.</given-names></name><name><surname>Moraes</surname><given-names>C. T.</given-names></name></person-group> (<year>2007</year>). <article-title>Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>104</volume>, <fpage>14163</fpage>–<lpage>14168</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0705738104</pub-id><pub-id pub-id-type="pmid">17715058</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funfschilling</surname><given-names>U.</given-names></name><name><surname>Supplie</surname><given-names>L. M.</given-names></name><name><surname>Mahad</surname><given-names>D.</given-names></name><name><surname>Boretius</surname><given-names>S.</given-names></name><name><surname>Saab</surname><given-names>A. S.</given-names></name><name><surname>Edgar</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity</article-title>. <source/>Nature
<volume>485</volume>, <fpage>517</fpage>–<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1038/nature11007</pub-id><pub-id pub-id-type="pmid">22622581</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garbern</surname><given-names>J.</given-names></name><name><surname>Yool</surname><given-names>D. A.</given-names></name><name><surname>Moore</surname><given-names>G. J.</given-names></name><name><surname>Wilds</surname><given-names>I.</given-names></name><name><surname>Faulk</surname><given-names>M.</given-names></name><name><surname>Klugmann</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation</article-title>. <source/>Brain
<volume>125</volume>, <fpage>551</fpage>–<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awf043</pub-id><pub-id pub-id-type="pmid">11872612</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdts</surname><given-names>J.</given-names></name><name><surname>Brace</surname><given-names>E. J.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>DiAntonio</surname><given-names>A.</given-names></name><name><surname>Milbrandt</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>SARM1 activation triggers axon degeneration locally via NAD(+) destruction</article-title>. <source/>Science
<volume>348</volume>, <fpage>453</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1126/science.1258366</pub-id><pub-id pub-id-type="pmid">25908823</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdts</surname><given-names>J.</given-names></name><name><surname>Summers</surname><given-names>D. W.</given-names></name><name><surname>Milbrandt</surname><given-names>J.</given-names></name><name><surname>DiAntonio</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Axon self-destruction: new links among SARM1, MAPKs, and NAD+ metabolism</article-title>. <source/>Neuron
<volume>89</volume>, <fpage>449</fpage>–<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.12.023</pub-id><pub-id pub-id-type="pmid">26844829</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghabriel</surname><given-names>M. N.</given-names></name><name><surname>Allt</surname><given-names>G.</given-names></name></person-group> (<year>1981</year>). <article-title>Incisures of schmidt-lanterman</article-title>. <source/>Prog. Neurobiol.
<volume>17</volume>, <fpage>25</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(81)90003-4</pub-id><pub-id pub-id-type="pmid">7323300</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>A.</given-names></name><name><surname>Manrique-Hoyos</surname><given-names>N.</given-names></name><name><surname>Voigt</surname><given-names>A.</given-names></name><name><surname>Schulz</surname><given-names>J. B.</given-names></name><name><surname>Kreutzfeldt</surname><given-names>M.</given-names></name><name><surname>Merkler</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Targeted ablation of oligodendrocytes triggers axonal damage</article-title>. <source/>PLoS ONE
<volume>6</volume>:<fpage>e22735</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022735</pub-id><pub-id pub-id-type="pmid">21818378</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>C. S.</given-names></name><name><surname>Sherman</surname><given-names>D. L.</given-names></name><name><surname>Fleetwood-Walker</surname><given-names>S. M.</given-names></name><name><surname>Cottrell</surname><given-names>D. F.</given-names></name><name><surname>Tait</surname><given-names>S.</given-names></name><name><surname>Garry</surname><given-names>E. M.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice</article-title>. <source/>Neuron
<volume>26</volume>, <fpage>523</fpage>–<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)81184-8</pub-id><pub-id pub-id-type="pmid">10839370</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilley</surname><given-names>J.</given-names></name><name><surname>Coleman</surname><given-names>M. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons</article-title>. <source/>PLoS Biol.
<volume>8</volume>:<fpage>e1000300</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1000300</pub-id><pub-id pub-id-type="pmid">20126265</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilley</surname><given-names>J.</given-names></name><name><surname>Orsomando</surname><given-names>G.</given-names></name><name><surname>Nascimento-Ferreira</surname><given-names>I.</given-names></name><name><surname>Coleman</surname><given-names>M. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Absence of SARM1 rescues development and survival of NMNAT2-deficient axons</article-title>. <source/>Cell Rep.
<volume>10</volume>, <fpage>1974</fpage>–<lpage>1981</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.02.060</pub-id><pub-id pub-id-type="pmid">25818290</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilley</surname><given-names>J.</given-names></name><name><surname>Ribchester</surname><given-names>R. R.</given-names></name><name><surname>Coleman</surname><given-names>M. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Sarm1 Deletion, but Not Wld(S), Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy</article-title>. <source/>Cell Rep.
<volume>21</volume>, <fpage>10</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.027</pub-id><pub-id pub-id-type="pmid">28978465</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goebbels</surname><given-names>S.</given-names></name><name><surname>Wieser</surname><given-names>G. L.</given-names></name><name><surname>Pieper</surname><given-names>A.</given-names></name><name><surname>Spitzer</surname><given-names>S.</given-names></name><name><surname>Weege</surname><given-names>B.</given-names></name><name><surname>Yan</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A neuronal PI(3,4,5)P3-dependent program of oligodendrocyte precursor recruitment and myelination</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>10</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4425</pub-id><pub-id pub-id-type="pmid">27775720</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Sanchez</surname><given-names>J. A.</given-names></name><name><surname>Carty</surname><given-names>L.</given-names></name><name><surname>Iruarrizaga-Lejarreta</surname><given-names>M.</given-names></name><name><surname>Palomo-Irigoyen</surname><given-names>M.</given-names></name><name><surname>Varela-Rey</surname><given-names>M.</given-names></name><name><surname>Griffith</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves</article-title>. <source/>J. Cell Biol.
<volume>210</volume>, <fpage>153</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201503019</pub-id><pub-id pub-id-type="pmid">26150392</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>I. R.</given-names></name><name><surname>Klugmann</surname><given-names>M.</given-names></name><name><surname>Anderson</surname><given-names>T. J.</given-names></name><name><surname>Yool</surname><given-names>D.</given-names></name><name><surname>Thomson</surname><given-names>C. E.</given-names></name><name><surname>Schwab</surname><given-names>M. H.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Axonal swellings and degeneration in mice lacking the major proteolipid of myelin</article-title>. <source/>Science
<volume>280</volume>, <fpage>1610</fpage>–<lpage>1613</lpage>. <pub-id pub-id-type="doi">10.1126/science.280.5369.1610</pub-id><pub-id pub-id-type="pmid">9616125</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groh</surname><given-names>J.</given-names></name><name><surname>Martini</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: understanding pathogenesis and chances for treatment</article-title>. <source/>Glia
<volume>65</volume>, <fpage>1407</fpage>–<lpage>1422</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23162</pub-id><pub-id pub-id-type="pmid">28568966</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruenenfelder</surname><given-names>F. I.</given-names></name><name><surname>Thomson</surname><given-names>G.</given-names></name><name><surname>Penderis</surname><given-names>J.</given-names></name><name><surname>Edgar</surname><given-names>J. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease</article-title>. <source/>J. Anat.
<volume>219</volume>, <fpage>33</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7580.2011.01363.x</pub-id><pub-id pub-id-type="pmid">21401588</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Gan</surname><given-names>J.</given-names></name><name><surname>Selfridge</surname><given-names>J.</given-names></name><name><surname>Cobb</surname><given-names>S.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Reversal of neurological defects in a mouse model of Rett syndrome</article-title>. <source/>Science
<volume>315</volume>, <fpage>1143</fpage>–<lpage>1147</lpage>. <pub-id pub-id-type="doi">10.1126/science.1138389</pub-id><pub-id pub-id-type="pmid">17289941</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartline</surname><given-names>D. K.</given-names></name><name><surname>Colman</surname><given-names>D. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Rapid conduction and the evolution of giant axons and myelinated fibers</article-title>. <source/>Curr. Biol.
<volume>17</volume>, <fpage>29</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2006.11.042</pub-id><pub-id pub-id-type="pmid">17208176</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildebrand</surname><given-names>C.</given-names></name><name><surname>Bowe</surname><given-names>C. M.</given-names></name><name><surname>Remahl</surname><given-names>I. N.</given-names></name></person-group> (<year>1994</year>). <article-title>Myelination and myelin sheath remodelling in normal and pathological PNS nerve fibres</article-title>. <source/>Prog. Neurobiol.
<volume>43</volume>, <fpage>85</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(94)90010-8</pub-id><pub-id pub-id-type="pmid">7972854</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinckelmann</surname><given-names>M. V.</given-names></name><name><surname>Virlogeux</surname><given-names>A.</given-names></name><name><surname>Niehage</surname><given-names>C.</given-names></name><name><surname>Poujol</surname><given-names>C.</given-names></name><name><surname>Choquet</surname><given-names>D.</given-names></name><name><surname>Hoflack</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>13233</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms13233</pub-id><pub-id pub-id-type="pmid">27775035</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>E. G.</given-names></name><name><surname>Appel</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>The cell biology of CNS myelination</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>39</volume>, <fpage>93</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2016.04.013</pub-id><pub-id pub-id-type="pmid">27152449</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>S.</given-names></name><name><surname>Ghergurovich</surname><given-names>J. M.</given-names></name><name><surname>Morscher</surname><given-names>R. J.</given-names></name><name><surname>Jang</surname><given-names>C.</given-names></name><name><surname>Teng</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Glucose feeds the TCA cycle via circulating lactate</article-title>. <source/>Nature
<volume>551</volume>, <fpage>115</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1038/nature24057</pub-id><pub-id pub-id-type="pmid">29045397</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israeli</surname><given-names>E.</given-names></name><name><surname>Dryanovski</surname><given-names>D. I.</given-names></name><name><surname>Schumacker</surname><given-names>P. T.</given-names></name><name><surname>Chandel</surname><given-names>N. S.</given-names></name><name><surname>Singer</surname><given-names>J. D.</given-names></name><name><surname>Julien</surname><given-names>J. P.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in giant axonal neuropathy</article-title>. <source/>Hum. Mol. Genet.
<volume>25</volume>, <fpage>2143</fpage>–<lpage>2157</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw081</pub-id><pub-id pub-id-type="pmid">27000625</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>S. Y.</given-names></name><name><surname>Shin</surname><given-names>Y. K.</given-names></name><name><surname>Park</surname><given-names>S. Y.</given-names></name><name><surname>Park</surname><given-names>J. Y.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Yoo</surname><given-names>Y. H.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Autophagic myelin destruction by Schwann cells during Wallerian degeneration and segmental demyelination</article-title>. <source/>Glia
<volume>64</volume>, <fpage>730</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22957</pub-id><pub-id pub-id-type="pmid">26712109</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jedele</surname><given-names>K. B.</given-names></name></person-group> (<year>2007</year>). <article-title>The overlapping spectrum of rett and angelman syndromes: a clinical review</article-title>. <source/>Semin. Pediatr. Neurol.
<volume>14</volume>, <fpage>108</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.spen.2007.07.002</pub-id><pub-id pub-id-type="pmid">17980307</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judson</surname><given-names>M. C.</given-names></name><name><surname>Burette</surname><given-names>A. C.</given-names></name><name><surname>Thaxton</surname><given-names>C. L.</given-names></name><name><surname>Pribisko</surname><given-names>A. L.</given-names></name><name><surname>Shen</surname><given-names>M. D.</given-names></name><name><surname>Rumple</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Decreased axon caliber underlies loss of fiber tract integrity, disproportional reductions in white matter volume, and microcephaly in angelman syndrome model mice</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>7347</fpage>–<lpage>7361</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0037-17.2017</pub-id><pub-id pub-id-type="pmid">28663201</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. J.</given-names></name><name><surname>Liu</surname><given-names>I. Y.</given-names></name><name><surname>Wang</surname><given-names>M. B.</given-names></name><name><surname>Srivatsan</surname><given-names>E. S.</given-names></name></person-group> (<year>2016</year>). <article-title>A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer</article-title>. <source/>Hum. Genet.
<volume>135</volume>, <fpage>675</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-016-1659-5</pub-id><pub-id pub-id-type="pmid">27023907</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapitein</surname><given-names>L. C.</given-names></name><name><surname>Hoogenraad</surname><given-names>C. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Which way to go? Cytoskeletal organization and polarized transport in neurons</article-title>. <source/>Mol. Cell Neurosci.
<volume>46</volume>, <fpage>9</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2010.08.015</pub-id><pub-id pub-id-type="pmid">20817096</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassmann</surname><given-names>C. M.</given-names></name><name><surname>Nave</surname><given-names>K. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Oligodendroglial impact on axonal function and survival - a hypothesis</article-title>. <source/>Curr. Opin. Neurol.
<volume>21</volume>, <fpage>235</fpage>–<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0b013e328300c71f</pub-id><pub-id pub-id-type="pmid">18451704</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassmann</surname><given-names>C. M.</given-names></name><name><surname>Lappe-Siefke</surname><given-names>C.</given-names></name><name><surname>Baes</surname><given-names>M.</given-names></name><name><surname>Brugger</surname><given-names>B.</given-names></name><name><surname>Mildner</surname><given-names>A.</given-names></name><name><surname>Werner</surname><given-names>H. B.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes</article-title>. <source/>Nat. Genet.
<volume>39</volume>, <fpage>969</fpage>–<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1038/ng2070</pub-id><pub-id pub-id-type="pmid">17643102</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>S.</given-names></name><name><surname>Berger</surname><given-names>J.</given-names></name><name><surname>Aubourg</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects</article-title>. <source/>Biochim. Biophys. Acta
<volume>1822</volume>, <fpage>1465</fpage>–<lpage>1474</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2012.03.012</pub-id><pub-id pub-id-type="pmid">22483867</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kevenaar</surname><given-names>J. T.</given-names></name><name><surname>Hoogenraad</surname><given-names>C. C.</given-names></name></person-group> (<year>2015</year>). <article-title>The axonal cytoskeleton: from organization to function</article-title>. <source/>Front. Mol. Neurosci.
<volume>8</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2015.00044</pub-id><pub-id pub-id-type="pmid">26321907</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Maynard</surname><given-names>J. C.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Strickland</surname><given-names>A.</given-names></name><name><surname>Sherman</surname><given-names>D. L.</given-names></name><name><surname>Brophy</surname><given-names>P. J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Schwann cell O-GlcNAc glycosylation is required for myelin maintenance and axon integrity</article-title>. <source/>J. Neurosci.
<volume>36</volume>, <fpage>9633</fpage>–<lpage>9646</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1235-16.2016</pub-id><pub-id pub-id-type="pmid">27629714</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkcaldie</surname><given-names>M. T. K.</given-names></name><name><surname>Dwyer</surname><given-names>S. T.</given-names></name></person-group> (<year>2017</year>). <article-title>The third wave: intermediate filaments in the maturing nervous system</article-title>. <source/>Mol. Cell. Neurosci.. <volume>84</volume>, <fpage>68</fpage>–<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2017.05.010</pub-id><pub-id pub-id-type="pmid">28554564</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>L. L.</given-names></name><name><surname>Brady</surname><given-names>S. T.</given-names></name></person-group> (<year>1994</year>). <article-title>Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells</article-title>. <source/>J. Neurosci.
<volume>14</volume>, <fpage>7440</fpage>–<lpage>7450</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.14-12-07440.1994</pub-id><pub-id pub-id-type="pmid">7996186</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>L. L.</given-names></name><name><surname>Witt</surname><given-names>A. S.</given-names></name><name><surname>Payne</surname><given-names>H. R.</given-names></name><name><surname>Shine</surname><given-names>H. D.</given-names></name><name><surname>Brady</surname><given-names>S. T.</given-names></name></person-group> (<year>2001</year>). <article-title>Changes in microtubule stability and density in myelin-deficient shiverer mouse CNS axons</article-title>. <source/>J. Neurosci.
<volume>21</volume>, <fpage>2288</fpage>–<lpage>2297</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-07-02288.2001</pub-id><pub-id pub-id-type="pmid">11264304</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirschner</surname><given-names>D. A.</given-names></name><name><surname>Ganser</surname><given-names>A. L.</given-names></name></person-group> (<year>1980</year>). <article-title>Compact myelin exists in the absence of basic protein in the shiverer mutant mouse</article-title>. <source/>Nature
<volume>283</volume>, <fpage>207</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1038/283207a0</pub-id><pub-id pub-id-type="pmid">6153124</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>D.</given-names></name><name><surname>Martini</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Myelin and macrophages in the PNS: an intimate relationship in trauma and disease</article-title>. <source/>Brain Res.
<volume>1641</volume>, <fpage>130</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.11.033</pub-id><pub-id pub-id-type="pmid">26631844</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobsar</surname><given-names>I.</given-names></name><name><surname>Berghoff</surname><given-names>M.</given-names></name><name><surname>Samsam</surname><given-names>M.</given-names></name><name><surname>Wessig</surname><given-names>C.</given-names></name><name><surname>Mäurer</surname><given-names>M.</given-names></name><name><surname>Toyka</surname><given-names>K. V.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Preserved myelin integrity and reduced axonopathy in GJB132-deficient mice lacking the recombination activating gene-1</article-title>. <source/>Brain
<volume>126</volume>, <fpage>804</fpage>–<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awg072</pub-id><pub-id pub-id-type="pmid">12615640</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppel</surname><given-names>H.</given-names></name><name><surname>Innocenti</surname><given-names>G. M.</given-names></name></person-group> (<year>1983</year>). <article-title>Is there a genuine exuberancy of callosal projections in development? A quantitative electron microscopic study in the cat</article-title>. <source/>Neurosci. Lett.
<volume>41</volume>, <fpage>33</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(83)90219-7</pub-id><pub-id pub-id-type="pmid">6316219</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasnow</surname><given-names>A. M.</given-names></name><name><surname>Ford</surname><given-names>M. C.</given-names></name><name><surname>Valdivia</surname><given-names>L. E.</given-names></name><name><surname>Wilson</surname><given-names>S. W.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Regulation of developing myelin sheath elongation by oligodendrocyte calcium transients <italic>in vivo</italic></article-title>. <source/>Nat. Neurosci.
<volume>21</volume>, <fpage>24</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-017-0031-y</pub-id><pub-id pub-id-type="pmid">29230052</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaMantia</surname><given-names>A. S.</given-names></name><name><surname>Rakic</surname><given-names>P.</given-names></name></person-group> (<year>1990</year>). <article-title>Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey</article-title>. <source/>J. Comp. Neurol.
<volume>291</volume>, <fpage>520</fpage>–<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1002/cne.902910404</pub-id><pub-id pub-id-type="pmid">2329189</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampert</surname><given-names>P. W.</given-names></name></person-group> (<year>1967</year>). <article-title>A comparative electron microscopic study of reactive, degenerating, regenerating and dystrophic axons</article-title>. <source/>J. Neuropath. Exp. Neurol
<volume>26</volume>, <fpage>345</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-196707000-00001</pub-id><pub-id pub-id-type="pmid">5229871</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappe-Siefke</surname><given-names>C.</given-names></name><name><surname>Goebbels</surname><given-names>S.</given-names></name><name><surname>Gravel</surname><given-names>M.</given-names></name><name><surname>Nicksch</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Braun</surname><given-names>P. E.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Disruption of the <italic>CNP</italic> gene uncouples oligodendroglial functions in axonal support and myelination</article-title>. <source/>Nat. Genet.
<volume>33</volume>, <fpage>366</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1038/ng1095</pub-id><pub-id pub-id-type="pmid">12590258</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Leach</surname><given-names>M. K.</given-names></name><name><surname>Redmond</surname><given-names>S. A.</given-names></name><name><surname>Chong</surname><given-names>S. Y.</given-names></name><name><surname>Mellon</surname><given-names>S. H.</given-names></name><name><surname>Tuck</surname><given-names>S. J.</given-names></name><etal></etal></person-group>. (<year>2012a</year>). <article-title>A culture system to study oligodendrocyte myelination processes using engineered nanofibers</article-title>. <source/>Nat. Methods
<volume>9</volume>, <fpage>917</fpage>–<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2105</pub-id><pub-id pub-id-type="pmid">22796663</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Morrison</surname><given-names>B. M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lengacher</surname><given-names>S.</given-names></name><name><surname>Farah</surname><given-names>M. H.</given-names></name><name><surname>Hoffman</surname><given-names>P. N.</given-names></name><etal></etal></person-group>. (<year>2012b</year>). <article-title>Oligodendroglia metabolically support axons and contribute to neurodegeneration</article-title>. <source/>Nature
<volume>487</volume>, <fpage>443</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1038/nature11314</pub-id><pub-id pub-id-type="pmid">22801498</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Ghandour</surname><given-names>K.</given-names></name><name><surname>Radovanovic</surname><given-names>D.</given-names></name><name><surname>Shy</surname><given-names>R. R.</given-names></name><name><surname>Krajewski</surname><given-names>K. M.</given-names></name><name><surname>Shy</surname><given-names>M. E.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies</article-title>. <source/>Arch. Neurol.
<volume>64</volume>, <fpage>974</fpage>–<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.64.7.974</pub-id><pub-id pub-id-type="pmid">17620487</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Leal</surname><given-names>R.</given-names></name><name><surname>Alvarez</surname><given-names>J.</given-names></name><name><surname>Court</surname><given-names>F. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Origin of axonal proteins: is the axon-schwann cell unit a functional syncytium?</article-title>
<source/>Cytoskeleton (Hoboken)
<volume>73</volume>, <fpage>629</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1002/cm.21319</pub-id><pub-id pub-id-type="pmid">27490284</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loreto</surname><given-names>A.</given-names></name><name><surname>Di</surname><given-names>S. M.</given-names></name><name><surname>Gering</surname><given-names>M.</given-names></name><name><surname>Conforti</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Wallerian degeneration is executed by an NMN-SARM1-dependent late Ca(2+) influx but only modestly influenced by Mitochondria</article-title>. <source/>Cell Rep.
<volume>13</volume>, <fpage>2539</fpage>–<lpage>2552</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.11.032</pub-id><pub-id pub-id-type="pmid">26686637</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lüders</surname><given-names>K. A.</given-names></name><name><surname>Patzig</surname><given-names>J.</given-names></name><name><surname>Simons</surname><given-names>M.</given-names></name><name><surname>Nave</surname><given-names>K. A.</given-names></name><name><surname>Werner</surname><given-names>H. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetic dissection of oligodendroglial and neuronal Plp1 function in a novel mouse model of spastic paraplegia type 2</article-title>. <source/>Glia
<volume>65</volume>, <fpage>1762</fpage>–<lpage>1776</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23193</pub-id><pub-id pub-id-type="pmid">28836307</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundgaard</surname><given-names>I.</given-names></name><name><surname>Luzhynskaya</surname><given-names>A.</given-names></name><name><surname>Stockley</surname><given-names>J. H.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Evans</surname><given-names>K. A.</given-names></name><name><surname>Swire</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes</article-title>. <source/>PLoS Biol.
<volume>11</volume>:<fpage>e1001743</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1001743</pub-id><pub-id pub-id-type="pmid">24391468</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luse</surname><given-names>S. A.</given-names></name></person-group> (<year>1956</year>). <article-title>Electron microscopic observations of the central nervous system</article-title>. <source/>J. Biophys. Biochem. Cytol.
<volume>2</volume>, <fpage>531</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.2.5.531</pub-id><pub-id pub-id-type="pmid">13376632</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>T. G. A.</given-names></name><name><surname>Reiner</surname><given-names>M.</given-names></name><name><surname>Beirowski</surname><given-names>B.</given-names></name><name><surname>Mi</surname><given-names>W. Q.</given-names></name><name><surname>Emanuelli</surname><given-names>M.</given-names></name><name><surname>Wagner</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Wallerian degeneration of injured axons and synapses is delayed by a <italic>Ube4b/Nmnat</italic> chimeric gene</article-title>. <source/>Nat. Neurosci.
<volume>4</volume>, <fpage>1199</fpage>–<lpage>1206</lpage>. <pub-id pub-id-type="doi">10.1038/nn770</pub-id><pub-id pub-id-type="pmid">11770485</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname><given-names>S.</given-names></name><name><surname>Twelvetrees</surname><given-names>A. E.</given-names></name><name><surname>Moughamian</surname><given-names>A. J.</given-names></name><name><surname>Holzbaur</surname><given-names>E. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Axonal transport: cargo-specific mechanisms of motility and regulation</article-title>. <source/>Neuron
<volume>84</volume>, <fpage>292</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.10.019</pub-id><pub-id pub-id-type="pmid">25374356</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahad</surname><given-names>D. J.</given-names></name><name><surname>Ziabreva</surname><given-names>I.</given-names></name><name><surname>Campbell</surname><given-names>G.</given-names></name><name><surname>Lax</surname><given-names>N.</given-names></name><name><surname>White</surname><given-names>K.</given-names></name><name><surname>Hanson</surname><given-names>P. S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Mitochondrial changes within axons in multiple sclerosis</article-title>. <source/>Brain
<volume>132</volume>, <fpage>1161</fpage>–<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp046</pub-id><pub-id pub-id-type="pmid">19293237</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makhaeva</surname><given-names>G. F.</given-names></name><name><surname>Radchenko</surname><given-names>E. V.</given-names></name><name><surname>Palyulin</surname><given-names>V. A.</given-names></name><name><surname>Rudakova</surname><given-names>E. V.</given-names></name><name><surname>Aksinenko</surname><given-names>A. Y.</given-names></name><name><surname>Sokolov</surname><given-names>V. B.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects</article-title>. <source/>Chem. Biol. Interact.
<volume>203</volume>, <fpage>231</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2012.10.012</pub-id><pub-id pub-id-type="pmid">23123251</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname><given-names>R.</given-names></name><name><surname>Mohajeri</surname><given-names>M. H.</given-names></name><name><surname>Kasper</surname><given-names>S.</given-names></name><name><surname>Giese</surname><given-names>K. P.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>Mice doubly deficient in the genes for MPZ and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin</article-title>. <source/>J. Neurosci.
<volume>15</volume>, <fpage>4488</fpage>–<lpage>4495</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-06-04488.1995</pub-id><pub-id pub-id-type="pmid">7540676</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michailov</surname><given-names>G. V.</given-names></name><name><surname>Sereda</surname><given-names>M. W.</given-names></name><name><surname>Brinkmann</surname><given-names>B. G.</given-names></name><name><surname>Fischer</surname><given-names>T. M.</given-names></name><name><surname>Haug</surname><given-names>B.</given-names></name><name><surname>Birchmeier</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Axonal Neuregulin-1 regulates myelin sheath thickness</article-title>. <source/>Science
<volume>304</volume>, <fpage>700</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1126/science.1095862</pub-id><pub-id pub-id-type="pmid">15044753</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikelberg</surname><given-names>F. S.</given-names></name><name><surname>Drance</surname><given-names>S. M.</given-names></name><name><surname>Schulzer</surname><given-names>M.</given-names></name><name><surname>Yidegiligne</surname><given-names>H. M.</given-names></name><name><surname>Weis</surname><given-names>M. M.</given-names></name></person-group> (<year>1989</year>). <article-title>The normal human optic nerve. Axon count and axon diameter distribution</article-title>. <source/>Ophthalmology
<volume>96</volume>, <fpage>1325</fpage>–<lpage>1328</lpage>. <pub-id pub-id-type="doi">10.1016/S0161-6420(89)32718-7</pub-id><pub-id pub-id-type="pmid">2780002</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>B. R.</given-names></name><name><surname>Press</surname><given-names>C.</given-names></name><name><surname>Daniels</surname><given-names>R. W.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Milbrandt</surname><given-names>J.</given-names></name><name><surname>DiAntonio</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration</article-title>. <source/>Nat. Neurosci.
<volume>12</volume>, <fpage>387</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2290</pub-id><pub-id pub-id-type="pmid">19287387</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Möbius</surname><given-names>W.</given-names></name><name><surname>Nave</surname><given-names>K. A.</given-names></name><name><surname>Werner</surname><given-names>H. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Electron microscopy of myelin: structure preservation by high-pressure freezing</article-title>. <source/>Brain Res.
<volume>1641</volume>, <fpage>92</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2016.02.027</pub-id><pub-id pub-id-type="pmid">26920467</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monk</surname><given-names>K. R.</given-names></name><name><surname>Feltri</surname><given-names>M. L.</given-names></name><name><surname>Taveggia</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>New insights on Schwann cell development</article-title>. <source/>Glia
<volume>63</volume>, <fpage>1376</fpage>–<lpage>1393</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22852</pub-id><pub-id pub-id-type="pmid">25921593</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsma</surname><given-names>P. C.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Fenn</surname><given-names>J. D.</given-names></name><name><surname>Jung</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Local regulation of neurofilament transport by myelinating cells</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>2979</fpage>–<lpage>2988</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4502-13.2014</pub-id><pub-id pub-id-type="pmid">24553938</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Morell</surname><given-names>P.</given-names></name></person-group> (<year>1984</year>). <source/>Myelin. <publisher-name>Plenum Press</publisher-name>: <publisher-loc>New York, NY; London</publisher-loc>.</mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morfini</surname><given-names>G. A.</given-names></name><name><surname>Burns</surname><given-names>M.</given-names></name><name><surname>Binder</surname><given-names>L. I.</given-names></name><name><surname>Kanaan</surname><given-names>N. M.</given-names></name><name><surname>LaPointe</surname><given-names>N.</given-names></name><name><surname>Bosco</surname><given-names>D. A.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Axonal transport defects in neurodegenerative diseases</article-title>. <source/>J. Neurosci. <volume>29</volume>, <fpage>12776</fpage>–<lpage>12786</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3463-09.2009</pub-id><pub-id pub-id-type="pmid">19828789</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosser</surname><given-names>J.</given-names></name><name><surname>Douar</surname><given-names>A. M.</given-names></name><name><surname>Sarde</surname><given-names>C. O.</given-names></name><name><surname>Kioschis</surname><given-names>P.</given-names></name><name><surname>Feil</surname><given-names>R.</given-names></name><name><surname>Moser</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>1993</year>). <article-title>Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters</article-title>. <source/>Nature
<volume>361</volume>, <fpage>726</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1038/361726a0</pub-id><pub-id pub-id-type="pmid">8441467</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>K. A.</given-names></name></person-group> (<year>2010a</year>). <article-title>Myelination and support of axonal integrity by glia</article-title>. <source/>Nature
<volume>468</volume>, <fpage>244</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1038/nature09614</pub-id><pub-id pub-id-type="pmid">21068833</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>K. A.</given-names></name></person-group> (<year>2010b</year>). <article-title>Myelination and the trophic support of long axons</article-title>. <source/>Nat. Rev. Neurosci.
<volume>11</volume>, <fpage>275</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2797</pub-id><pub-id pub-id-type="pmid">20216548</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>K. A.</given-names></name><name><surname>Werner</surname><given-names>H. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Myelination of the nervous system: mechanisms and functions</article-title>. <source/>Annu. Rev. Cell Dev. Biol.
<volume>30</volume>, <fpage>503</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013101</pub-id><pub-id pub-id-type="pmid">25288117</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>K. A.</given-names></name><name><surname>Sereda</surname><given-names>M. W.</given-names></name><name><surname>Ehrenreich</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Mechanisms of disease: inherited demyelinating neuropathies–from basic to clinical research</article-title>. <source/>Nat. Clin. Pract. Neurol.
<volume>3</volume>, <fpage>453</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1038/ncpneuro0583</pub-id><pub-id pub-id-type="pmid">17671523</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>K.-A.</given-names></name><name><surname>Griffiths</surname><given-names>I. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Models of Pelizaeus-Merzbacher disease</article-title>, in <source/>Myelin Biology and Disorders, eds <person-group person-group-type="editor"><name><surname>Lazzarini</surname><given-names>R. A.</given-names></name><name><surname>Griffin</surname><given-names>J. W.</given-names></name><name><surname>Lassmann</surname><given-names>H.</given-names></name><name><surname>Nave</surname><given-names>K.-A.</given-names></name><name><surname>Miller</surname><given-names>R. H.</given-names></name><name><surname>Trapp</surname><given-names>B. D.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>), <fpage>1125</fpage>–<lpage>1142</lpage>.</mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>A. A.</given-names></name><name><surname>Logan</surname><given-names>A. M.</given-names></name><name><surname>Schmidt</surname><given-names>E. J.</given-names></name><name><surname>Robinson</surname><given-names>F. L.</given-names></name></person-group> (<year>2013</year>). <article-title>The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression</article-title>. <source/>Hum. Mol. Genet.
<volume>22</volume>, <fpage>1493</fpage>–<lpage>1506</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds562</pub-id><pub-id pub-id-type="pmid">23297362</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>G. A.</given-names></name><name><surname>Valentijn</surname><given-names>L. J.</given-names></name><name><surname>Cherryson</surname><given-names>A. K.</given-names></name><name><surname>Kennerson</surname><given-names>M. L.</given-names></name><name><surname>Bragg</surname><given-names>T. L.</given-names></name><name><surname>DeKroon</surname><given-names>R. M.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies</article-title>. <source/>Nat. Genet.
<volume>6</volume>, <fpage>263</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1038/ng0394-263</pub-id><pub-id pub-id-type="pmid">8012388</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijland</surname><given-names>P. G.</given-names></name><name><surname>Michailidou</surname><given-names>I.</given-names></name><name><surname>Witte</surname><given-names>M. E.</given-names></name><name><surname>Mizee</surname><given-names>M. R.</given-names></name><name><surname>van der Pol</surname><given-names>S. M.</given-names></name><name><surname>Van Het Hof</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions</article-title>. <source/>Glia
<volume>62</volume>, <fpage>1125</fpage>–<lpage>1141</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22667</pub-id><pub-id pub-id-type="pmid">24692237</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikic</surname><given-names>I.</given-names></name><name><surname>Merkler</surname><given-names>D.</given-names></name><name><surname>Sorbara</surname><given-names>C.</given-names></name><name><surname>Brinkoetter</surname><given-names>M.</given-names></name><name><surname>Kreutzfeldt</surname><given-names>M.</given-names></name><name><surname>Bareyre</surname><given-names>F. M.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis</article-title>. <source/>Nat. Med.
<volume>17</volume>, <fpage>495</fpage>–<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2324</pub-id><pub-id pub-id-type="pmid">21441916</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>L. T.</given-names></name><name><surname>Goetz</surname><given-names>B. D.</given-names></name><name><surname>Kwiecien</surname><given-names>J. M.</given-names></name><name><surname>Delaney</surname><given-names>K. H.</given-names></name><name><surname>Fletch</surname><given-names>A. L.</given-names></name><name><surname>Duncan</surname><given-names>I. D.</given-names></name></person-group> (<year>1999</year>). <article-title>Insertion of a retrotransposon in mbp disrupts mRNA splicing and myelination in a new mutant rat</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>3404</fpage>–<lpage>3413</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-09-03404.1999</pub-id><pub-id pub-id-type="pmid">10212300</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>E. M.</given-names></name><name><surname>Choi</surname><given-names>I. Y.</given-names></name><name><surname>Lim</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Zika virus directly infects peripheral neurons and induces cell death</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>1209</fpage>–<lpage>1212</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4612</pub-id><pub-id pub-id-type="pmid">28758997</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oluich</surname><given-names>L. J.</given-names></name><name><surname>Stratton</surname><given-names>J. A.</given-names></name><name><surname>Xing</surname><given-names>Y. L.</given-names></name><name><surname>Ng</surname><given-names>S. W.</given-names></name><name><surname>Cate</surname><given-names>H. S.</given-names></name><name><surname>Sah</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>8317</fpage>–<lpage>8330</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1053-12.2012</pub-id><pub-id pub-id-type="pmid">22699912</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterloh</surname><given-names>J. M.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Rooney</surname><given-names>T. M.</given-names></name><name><surname>Fox</surname><given-names>A. N.</given-names></name><name><surname>Adalbert</surname><given-names>R.</given-names></name><name><surname>Powell</surname><given-names>E. H.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>dSarm/Sarm1 is required for activation of an injury-induced axon death pathway</article-title>. <source/>Science
<volume>337</volume>, <fpage>481</fpage>–<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1126/science.1223899</pub-id><pub-id pub-id-type="pmid">22678360</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>B.</given-names></name><name><surname>Fromholt</surname><given-names>S. E.</given-names></name><name><surname>Hess</surname><given-names>E. J.</given-names></name><name><surname>Crawford</surname><given-names>T. O.</given-names></name><name><surname>Griffin</surname><given-names>J. W.</given-names></name><name><surname>Sheikh</surname><given-names>K. A.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice</article-title>. <source/>Exp. Neurol.
<volume>195</volume>, <fpage>208</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2005.04.017</pub-id><pub-id pub-id-type="pmid">15953602</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papandreou</surname><given-names>M. J.</given-names></name><name><surname>Leterrier</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>The functional architecture of axonal actin</article-title>. <source/>Mol. Cell. Neurosci.
<volume>18</volume>, <fpage>30041</fpage>–<lpage>30042</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2018.05.003</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patzig</surname><given-names>J.</given-names></name><name><surname>Erwig</surname><given-names>M. S.</given-names></name><name><surname>Tenzer</surname><given-names>S.</given-names></name><name><surname>Kusch</surname><given-names>K.</given-names></name><name><surname>Dibaj</surname><given-names>P.</given-names></name><name><surname>Mobius</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Septin/anillin filaments scaffold central nervous system myelin to accelerate nerve conduction</article-title>. <source/>Elife
<volume>5</volume>:<fpage>17119</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.17119</pub-id><pub-id pub-id-type="pmid">27504968</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>J. A.</given-names></name><name><surname>Lebrun-Julien</surname><given-names>F.</given-names></name><name><surname>Suter</surname><given-names>U.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanisms regulating myelination in the peripheral nervous system</article-title>. <source/>Trends Neurosci.
<volume>35</volume>, <fpage>123</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2011.11.006</pub-id><pub-id pub-id-type="pmid">22192173</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perge</surname><given-names>J. A.</given-names></name><name><surname>Koch</surname><given-names>K.</given-names></name><name><surname>Miller</surname><given-names>R.</given-names></name><name><surname>Sterling</surname><given-names>P.</given-names></name><name><surname>Balasubramanian</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>How the optic nerve allocates space, energy capacity, and information</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>7917</fpage>–<lpage>7928</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5200-08.2009</pub-id><pub-id pub-id-type="pmid">19535603</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perge</surname><given-names>J. A.</given-names></name><name><surname>Niven</surname><given-names>J. E.</given-names></name><name><surname>Mugnaini</surname><given-names>E.</given-names></name><name><surname>Balasubramanian</surname><given-names>V.</given-names></name><name><surname>Sterling</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Why do axons differ in caliber?</article-title>
<source/>J. Neurosci.
<volume>32</volume>, <fpage>626</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4254-11.2012</pub-id><pub-id pub-id-type="pmid">22238098</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>1988</year>). <article-title>Macrophages and microglia in the nervous system</article-title>. <source/>Trends Neurosci.
<volume>11</volume>, <fpage>273</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(88)90110-5</pub-id><pub-id pub-id-type="pmid">2465626</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Brown</surname><given-names>M. C.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>1987</year>). <article-title>The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration</article-title>. <source/>J. Exp. Med.
<volume>165</volume>, <fpage>1218</fpage>–<lpage>1223</lpage>. <pub-id pub-id-type="pmid">3559478</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Brown</surname><given-names>M. C.</given-names></name><name><surname>Lunn</surname><given-names>E. R.</given-names></name></person-group> (<year>1990</year>). <article-title>Very slow retrograde and Wallerian degeneration in the CNS of C57BL/Ola mice</article-title>. <source/>Eur. J. Neurosci.
<volume>3</volume>, <fpage>103</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="pmid">12106273</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A.</given-names></name></person-group> (<year>1966</year>). <article-title>The node of Ranvier in the central nervous system</article-title>. <source/>Quart. J. Exp. Physiol.
<volume>51</volume>, <fpage>229</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1113/expphysiol.1966.sp001852</pub-id><pub-id pub-id-type="pmid">5182351</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A.</given-names></name><name><surname>Vaughn</surname><given-names>J. E.</given-names></name></person-group> (<year>1967</year>). <article-title>Microtubules and filaments in the axons and astrocytes of early postnatal rat optic nerves</article-title>. <source/>J. Cell Biol.
<volume>32</volume>, <fpage>113</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.32.1.113</pub-id><pub-id pub-id-type="pmid">10976204</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohl</surname><given-names>H. B.</given-names></name><name><surname>Porcheri</surname><given-names>C.</given-names></name><name><surname>Mueggler</surname><given-names>T.</given-names></name><name><surname>Bachmann</surname><given-names>L. C.</given-names></name><name><surname>Martino</surname><given-names>G.</given-names></name><name><surname>Riethmacher</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>1069</fpage>–<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5035-10.2011</pub-id><pub-id pub-id-type="pmid">21248132</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poitelon</surname><given-names>Y.</given-names></name><name><surname>Lopez-Anido</surname><given-names>C.</given-names></name><name><surname>Catignas</surname><given-names>K.</given-names></name><name><surname>Berti</surname><given-names>C.</given-names></name><name><surname>Palmisano</surname><given-names>M.</given-names></name><name><surname>Williamson</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>879</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4316</pub-id><pub-id pub-id-type="pmid">27273766</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Previtali</surname><given-names>S. C.</given-names></name><name><surname>Quattrini</surname><given-names>A.</given-names></name><name><surname>Bolino</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Charcot-Marie-Tooth type 4B demyelinating neuropathy: deciphering the role of MTMR phosphatases</article-title>. <source/>Expert Rev. Mol. Med.
<volume>9</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1017/S1462399407000439</pub-id><pub-id pub-id-type="pmid">17880751</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Privat</surname><given-names>A.</given-names></name><name><surname>Jacque</surname><given-names>C.</given-names></name><name><surname>Bourre</surname><given-names>J. M.</given-names></name><name><surname>Dupouey</surname><given-names>P.</given-names></name><name><surname>Baumann</surname><given-names>N.</given-names></name></person-group> (<year>1979</year>). <article-title>Absence of the major dense line in myelin of the mutant mouse shiverer</article-title>. <source/>Neurosci. Lett.
<volume>12</volume>, <fpage>107</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(79)91489-7</pub-id><pub-id pub-id-type="pmid">460693</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pujol</surname><given-names>A.</given-names></name><name><surname>Hindelang</surname><given-names>C.</given-names></name><name><surname>Callizot</surname><given-names>N.</given-names></name><name><surname>Bartsch</surname><given-names>U.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Mandel</surname><given-names>J. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mousemodel for adrenomyeloneuropathy</article-title>. <source/>Hum. Mol. Genet.
<volume>11</volume>, <fpage>499</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/11.5.499</pub-id><pub-id pub-id-type="pmid">11875044</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rainier</surname><given-names>S.</given-names></name><name><surname>Bui</surname><given-names>M.</given-names></name><name><surname>Mark</surname><given-names>E.</given-names></name><name><surname>Thomas</surname><given-names>D.</given-names></name><name><surname>Tokarz</surname><given-names>D.</given-names></name><name><surname>Ming</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Neuropathy target esterase gene mutations cause motor neuron disease</article-title>. <source/>Am. J. Hum. Genet.
<volume>82</volume>, <fpage>780</fpage>–<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.12.018</pub-id><pub-id pub-id-type="pmid">18313024</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransom</surname><given-names>B. R.</given-names></name><name><surname>Butt</surname><given-names>A. M.</given-names></name><name><surname>Black</surname><given-names>J. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Ultrastructural identification of HRP-injected oligodendrocytes in the intact rat optic nerve</article-title>. <source/>Glia
<volume>4</volume>, <fpage>37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440040105</pub-id><pub-id pub-id-type="pmid">1828785</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>A. N.</given-names></name><name><surname>Baas</surname><given-names>P. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Polarity sorting of microtubules in the axon</article-title>. <source/>Trends Neurosci.
<volume>41</volume>, <fpage>77</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2017.11.002</pub-id><pub-id pub-id-type="pmid">29198454</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasband</surname><given-names>M. N.</given-names></name><name><surname>Peles</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>The nodes of ranvier: molecular assembly and maintenance</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>8</volume>:<fpage>a020495</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a020495</pub-id><pub-id pub-id-type="pmid">26354894</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Readhead</surname><given-names>C.</given-names></name><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Griffiths</surname><given-names>I. R.</given-names></name><name><surname>Nave</surname><given-names>K.-A.</given-names></name></person-group> (<year>1994</year>). <article-title>Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage</article-title>. <source/>Neuron
<volume>12</volume>, <fpage>583</fpage>–<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(94)90214-3</pub-id><pub-id pub-id-type="pmid">7512350</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>E. J.</given-names></name><name><surname>Kapoor</surname><given-names>R.</given-names></name><name><surname>Smith</surname><given-names>K. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible</article-title>. <source/>Brain
<volume>120</volume>, <fpage>2149</fpage>–<lpage>2157</lpage>. <pub-id pub-id-type="doi">10.1093/brain/120.12.2149</pub-id><pub-id pub-id-type="pmid">9448570</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reles</surname><given-names>A.</given-names></name><name><surname>Friede</surname><given-names>R. L.</given-names></name></person-group> (<year>1991</year>). <article-title>Axonal cytoskeleton at the nodes of Ranvier</article-title>. <source/>J. Neurocytol.
<volume>20</volume>, <fpage>450</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1007/BF01252273</pub-id><pub-id pub-id-type="pmid">1869882</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rich</surname><given-names>L. R.</given-names></name><name><surname>Brown</surname><given-names>A. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Fibre sub-type specific conduction reveals metabolic function in mouse sciatic nerve</article-title>. <source/>J. Physiol.
<volume>596</volume>, <fpage>1795</fpage>–<lpage>1812</lpage>. <pub-id pub-id-type="doi">10.1113/JP275680</pub-id><pub-id pub-id-type="pmid">29517809</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinholm</surname><given-names>J. E.</given-names></name><name><surname>Hamilton</surname><given-names>N. B.</given-names></name><name><surname>Kessaris</surname><given-names>N.</given-names></name><name><surname>Richardson</surname><given-names>W. D.</given-names></name><name><surname>Bergersen</surname><given-names>L. H.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of oligodendrocyte development and myelination by glucose and lactate</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>538</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3516-10.2011</pub-id><pub-id pub-id-type="pmid">21228163</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>A.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Pravtcheva</surname><given-names>D.</given-names></name><name><surname>Ruddle</surname><given-names>F.</given-names></name><name><surname>Hood</surname><given-names>L.</given-names></name></person-group> (<year>1985</year>). <article-title>Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice</article-title>. <source/>Cell
<volume>42</volume>, <fpage>149</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(85)80110-0</pub-id><pub-id pub-id-type="pmid">2410137</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>A. M.</given-names></name><name><surname>King</surname><given-names>R. H. M.</given-names></name><name><surname>Muddle</surname><given-names>J. R.</given-names></name><name><surname>Thomas</surname><given-names>P. K.</given-names></name></person-group> (<year>1997</year>). <article-title>Abnormal Schwann cell axon interactions in the Trembler-J mouse</article-title>. <source/>J. Anat.
<volume>190</volume>, <fpage>423</fpage>–<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1046/j.1469-7580.1997.19030423.x</pub-id><pub-id pub-id-type="pmid">9147228</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbluth</surname><given-names>J.</given-names></name></person-group> (<year>1980</year>). <article-title>Central myelin in the mouse mutant shiverer</article-title>. <source/>J. Comp. Neurol.
<volume>194</volume>, <fpage>639</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1002/cne.901940310</pub-id><pub-id pub-id-type="pmid">7451686</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbluth</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Multiple functions of the paranodal junction of myelinated nerve fibers</article-title>. <source/>J. Neurosci. Res.
<volume>87</volume>, <fpage>3250</fpage>–<lpage>3258</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.22013</pub-id><pub-id pub-id-type="pmid">19224642</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbluth</surname><given-names>J.</given-names></name><name><surname>Bobrowski-Khoury</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Paranodal dysmyelination in peripheral nerves of Trembler mice</article-title>. <source/>J. Neurosci. Res.
<volume>92</volume>, <fpage>476</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23326</pub-id><pub-id pub-id-type="pmid">24446165</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Coffee</surname><given-names>P.</given-names></name><name><surname>Smith</surname><given-names>G.</given-names></name><name><surname>Liem</surname><given-names>R. K. H.</given-names></name><name><surname>Brady</surname><given-names>S. T.</given-names></name><name><surname>Black</surname><given-names>M. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>6849</fpage>–<lpage>6861</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-18-06849.2000</pub-id><pub-id pub-id-type="pmid">10995829</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>M.</given-names></name><name><surname>Jové</surname><given-names>M.</given-names></name><name><surname>Schlüter</surname><given-names>A.</given-names></name><name><surname>Casasnovas</surname><given-names>C.</given-names></name><name><surname>Villarroya</surname><given-names>F.</given-names></name><name><surname>Guilera</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>6861</fpage>–<lpage>6876</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv375</pub-id><pub-id pub-id-type="pmid">26370417</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rushton</surname><given-names>W. A.</given-names></name></person-group> (<year>1951</year>). <article-title>A theory of the effects of fibre size in medullated nerve</article-title>. <source/>J. Physiol. (Lond).
<volume>115</volume>, <fpage>101</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1951.sp004655</pub-id><pub-id pub-id-type="pmid">14889433</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saab</surname><given-names>A. S.</given-names></name><name><surname>Tzvetavona</surname><given-names>I. D.</given-names></name><name><surname>Trevisiol</surname><given-names>A.</given-names></name><name><surname>Baltan</surname><given-names>S.</given-names></name><name><surname>Dibaj</surname><given-names>P.</given-names></name><name><surname>Kusch</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism</article-title>. <source/>Neuron
<volume>91</volume>, <fpage>119</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.05.016</pub-id><pub-id pub-id-type="pmid">27292539</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadeghian</surname><given-names>M.</given-names></name><name><surname>Mastrolia</surname><given-names>V.</given-names></name><name><surname>Rezaei</surname><given-names>H. A.</given-names></name><name><surname>Mosley</surname><given-names>A.</given-names></name><name><surname>Mullali</surname><given-names>G.</given-names></name><name><surname>Schiza</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>33249</fpage>. <pub-id pub-id-type="doi">10.1038/srep33249</pub-id><pub-id pub-id-type="pmid">27624721</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Nakagawa</surname><given-names>T.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>DiAntonio</surname><given-names>A.</given-names></name><name><surname>Milbrandt</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD(+) depletion</article-title>. <source/>Elife
<volume>5</volume>:<fpage>19749</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.19749</pub-id><pub-id pub-id-type="pmid">27735788</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheidt</surname><given-names>P.</given-names></name><name><surname>Friede</surname><given-names>R. L.</given-names></name></person-group> (<year>1987</year>). <article-title>Myelin phagocytosis in Wallerian degeneration. Properties of millipore chambers and immunocytochemical identification of cell populations</article-title>. <source/>Acta Neuropath. (Berl.)
<volume>75</volume>, <fpage>77</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/BF00686796</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schelski</surname><given-names>M.</given-names></name><name><surname>Bradke</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuronal polarization: from spatiotemporal signaling to cytoskeletal dynamics</article-title>. <source/>Mol. Cell. Neurosci.
<volume>84</volume>, <fpage>11</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2017.03.008</pub-id><pub-id pub-id-type="pmid">28363876</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenemann</surname><given-names>P. T.</given-names></name><name><surname>Sheehan</surname><given-names>M. J.</given-names></name><name><surname>Glotzer</surname><given-names>L. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Prefrontal white matter volume is disproportionately larger in humans than in other primates</article-title>. <source/>Nat. Neurosci.
<volume>8</volume>, <fpage>242</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1038/nn1394</pub-id><pub-id pub-id-type="pmid">15665874</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweigreiter</surname><given-names>R.</given-names></name><name><surname>Roots</surname><given-names>B. I.</given-names></name><name><surname>Bandtlow</surname><given-names>C. E.</given-names></name><name><surname>Gould</surname><given-names>R. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Understanding myelination through studying its evolution</article-title>. <source/>Int. Rev. Neurobiol.
<volume>73</volume>, <fpage>219</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7742(06)73007-0</pub-id><pub-id pub-id-type="pmid">16737906</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sereda</surname><given-names>M.</given-names></name><name><surname>Griffiths</surname><given-names>I. R.</given-names></name><name><surname>Pühlhofer</surname><given-names>A.</given-names></name><name><surname>Stewart</surname><given-names>H.</given-names></name><name><surname>Rossner</surname><given-names>M. J.</given-names></name><name><surname>Zimmermann</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>A transgenic rat model of Charcot-Marie-Tooth disease</article-title>. <source/>Neuron
<volume>16</volume>, <fpage>1049</fpage>–<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80128-2</pub-id><pub-id pub-id-type="pmid">8630243</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleigh</surname><given-names>J. N.</given-names></name><name><surname>Vagnoni</surname><given-names>A.</given-names></name><name><surname>Twelvetrees</surname><given-names>A. E.</given-names></name><name><surname>Schiavo</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Methodological advances in imaging intravital axonal transport</article-title>. <source/>F1000Res
<volume>6</volume>:<fpage>200</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.10433.1</pub-id><pub-id pub-id-type="pmid">28344778</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>C. M.</given-names></name><name><surname>Cooksey</surname><given-names>E.</given-names></name><name><surname>Duncan</surname><given-names>I. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>2718</fpage>–<lpage>2727</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4627-12.2013</pub-id><pub-id pub-id-type="pmid">23392698</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>H. V.</given-names></name><name><surname>Spalding</surname><given-names>J. M.</given-names></name></person-group> (<year>1959</year>). <article-title>Outbreak of paralysis in Morocco due to ortho-cresyl phosphate poisoning</article-title>. <source/>Lancet
<volume>2</volume>, <fpage>1019</fpage>–<lpage>1021</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(59)91486-2</pub-id><pub-id pub-id-type="pmid">13831987</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. J.</given-names></name><name><surname>Lassmann</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>The role of nitric oxide in multiple sclerosis</article-title>. <source/>Lancet Neurol.
<volume>1</volume>, <fpage>232</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(02)00102-3</pub-id><pub-id pub-id-type="pmid">12849456</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snaidero</surname><given-names>N.</given-names></name><name><surname>Simons</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Myelination at a glance</article-title>. <source/>J. Cell Sci.
<volume>127</volume>, <fpage>2999</fpage>–<lpage>3004</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.151043</pub-id><pub-id pub-id-type="pmid">25024457</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snaidero</surname><given-names>N.</given-names></name><name><surname>Mobius</surname><given-names>W.</given-names></name><name><surname>Czopka</surname><given-names>T.</given-names></name><name><surname>Hekking</surname><given-names>L. H.</given-names></name><name><surname>Mathisen</surname><given-names>C.</given-names></name><name><surname>Verkleij</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue</article-title>. <source/>Cell
<volume>156</volume>, <fpage>277</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.044</pub-id><pub-id pub-id-type="pmid">24439382</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snaidero</surname><given-names>N.</given-names></name><name><surname>Velte</surname><given-names>C.</given-names></name><name><surname>Myllykoski</surname><given-names>M.</given-names></name><name><surname>Raasakka</surname><given-names>A.</given-names></name><name><surname>Ignatev</surname><given-names>A.</given-names></name><name><surname>Werner</surname><given-names>H. B.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Antagonistic Functions of MBP and CNP Establish Cytosolic Channels in CNS Myelin</article-title>. <source/>Cell Rep.
<volume>18</volume>, <fpage>314</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.053</pub-id><pub-id pub-id-type="pmid">28076777</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokoloff</surname><given-names>L.</given-names></name><name><surname>Reivich</surname><given-names>M.</given-names></name><name><surname>Kennedy</surname><given-names>C.</given-names></name><name><surname>Des Rosiers</surname><given-names>M. H.</given-names></name><name><surname>Patlak</surname><given-names>C. S.</given-names></name><name><surname>Pettigrew</surname><given-names>K. D.</given-names></name><etal></etal></person-group>. (<year>1977</year>). <article-title>The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat</article-title>. <source/>J. Neurochem.
<volume>28</volume>, <fpage>897</fpage>–<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1977.tb10649.x</pub-id><pub-id pub-id-type="pmid">864466</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorbara</surname><given-names>C. D.</given-names></name><name><surname>Wagner</surname><given-names>N. E.</given-names></name><name><surname>Ladwig</surname><given-names>A.</given-names></name><name><surname>Nikic</surname><given-names>I.</given-names></name><name><surname>Merkler</surname><given-names>D.</given-names></name><name><surname>Kleele</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Pervasive axonal transport deficits in multiple sclerosis models</article-title>. <source/>Neuron
<volume>84</volume>, <fpage>1183</fpage>–<lpage>1190</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.11.006</pub-id><pub-id pub-id-type="pmid">25433639</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaulding</surname><given-names>E. L.</given-names></name><name><surname>Burgess</surname><given-names>R. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Accumulating evidence for axonal translation in neuronal homeostasis</article-title>. <source/>Front. Neurosci.
<volume>11</volume>:<fpage>312</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00312</pub-id><pub-id pub-id-type="pmid">28620277</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>P. S.</given-names></name><name><surname>Schaumberg</surname><given-names>H. H.</given-names></name></person-group> (<year>1977a</year>). <article-title>Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration</article-title>. <source/>J. Neuropath. Exp. Neurol.
<volume>36</volume>, <fpage>276</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="pmid">190357</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>P. S.</given-names></name><name><surname>Schaumberg</surname><given-names>H. H.</given-names></name></person-group> (<year>1977b</year>). <article-title>Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies</article-title>. <source/>J. Neuropath. Exp. Neurol.
<volume>36</volume>, <fpage>300</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="pmid">190358</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanford</surname><given-names>L. R.</given-names></name></person-group> (<year>1987</year>). <article-title>Conduction velocity variations minimize conduction time differences among retinal ganglion cell axons</article-title>. <source/>Science
<volume>238</volume>, <fpage>358</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1126/science.3659918</pub-id><pub-id pub-id-type="pmid">3659918</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stys</surname><given-names>P. K.</given-names></name><name><surname>Zamponi</surname><given-names>G. W.</given-names></name><name><surname>van</surname><given-names>M. J.</given-names></name><name><surname>Geurts</surname><given-names>J. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Will the real multiple sclerosis please stand up?</article-title>
<source/>Nat. Rev. Neurosci.
<volume>13</volume>, <fpage>507</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3275</pub-id><pub-id pub-id-type="pmid">22714021</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez-Sola</surname><given-names>M. L.</given-names></name><name><surname>Gonzalez-Delgado</surname><given-names>F. J.</given-names></name><name><surname>Pueyo-Morlans</surname><given-names>M.</given-names></name><name><surname>Medina-Bolivar</surname><given-names>O. C.</given-names></name><name><surname>Hernandez-Acosta</surname><given-names>N. C.</given-names></name><name><surname>Gonzalez-Gomez</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Neurons in the white matter of the adult human neocortex</article-title>. <source/>Front. Neuroanat.
<volume>3</volume>:<fpage>7</fpage>. <pub-id pub-id-type="doi">10.3389/neuro.05.007.2009</pub-id><pub-id pub-id-type="pmid">19543540</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supplie</surname><given-names>L. M.</given-names></name><name><surname>Duking</surname><given-names>T.</given-names></name><name><surname>Campbell</surname><given-names>G.</given-names></name><name><surname>Diaz</surname><given-names>F.</given-names></name><name><surname>Moraes</surname><given-names>C. T.</given-names></name><name><surname>Gotz</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Respiration-deficient astrocytes survive as glycolytic cells <italic>in vivo</italic></article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>4231</fpage>–<lpage>4242</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0756-16.2017</pub-id><pub-id pub-id-type="pmid">28314814</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susuki</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Myelin: a specialized membrane for cell communication</article-title>. <source/>Nat. Educ.
<volume>3</volume>:<fpage>59</fpage>.</mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suter</surname><given-names>U.</given-names></name><name><surname>Welcher</surname><given-names>A. A.</given-names></name><name><surname>Özcelik</surname><given-names>T.</given-names></name><name><surname>Snipes</surname><given-names>G. J.</given-names></name><name><surname>Kosaras</surname><given-names>B.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><etal></etal></person-group>. (<year>1992</year>). <article-title><italic>Trembler</italic> mouse carries a point mutation in a myelin gene</article-title>. <source/>Nature
<volume>356</volume>, <fpage>241</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1038/356241a0</pub-id><pub-id pub-id-type="pmid">1552943</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taveggia</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Schwann cells-axon interaction in myelination</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>39</volume>, <fpage>24</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2016.03.006</pub-id><pub-id pub-id-type="pmid">27089429</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taveggia</surname><given-names>C.</given-names></name><name><surname>Zanazzi</surname><given-names>G.</given-names></name><name><surname>Petrylak</surname><given-names>A.</given-names></name><name><surname>Yano</surname><given-names>H.</given-names></name><name><surname>Rosenbluth</surname><given-names>J.</given-names></name><name><surname>Einheber</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Neuregulin-1 type III determines the ensheathment fate of axons</article-title>. <source/>Neuron
<volume>47</volume>, <fpage>681</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.08.017</pub-id><pub-id pub-id-type="pmid">16129398</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tillotson</surname><given-names>R.</given-names></name><name><surname>Selfridge</surname><given-names>J.</given-names></name><name><surname>Koerner</surname><given-names>M. V.</given-names></name><name><surname>Gadalla</surname><given-names>K. K. E.</given-names></name><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>De</surname><given-names>S. D.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Radically truncated MeCP2 rescues Rett syndrome-like neurological defects</article-title>. <source/>Nature
<volume>550</volume>, <fpage>398</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1038/nature24058</pub-id><pub-id pub-id-type="pmid">29019980</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasch</surname><given-names>J.</given-names></name><name><surname>Macmillan</surname><given-names>A.</given-names></name></person-group> (<year>1957</year>). <article-title>The number of fibers in the corpus callosum of the white mouse</article-title>. <source/>J. Comp. Neurol.
<volume>107</volume>, <fpage>165</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1002/cne.901070107</pub-id><pub-id pub-id-type="pmid">13416412</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traka</surname><given-names>M.</given-names></name><name><surname>Podojil</surname><given-names>J. R.</given-names></name><name><surname>McCarthy</surname><given-names>D. P.</given-names></name><name><surname>Miller</surname><given-names>S. D.</given-names></name><name><surname>Popko</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Oligodendrocyte death results in immune-mediated CNS demyelination</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>65</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4193</pub-id><pub-id pub-id-type="pmid">26656646</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapp</surname><given-names>B. D.</given-names></name><name><surname>Nave</surname><given-names>K. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Multiple sclerosis: an immune or neurodegenerative disorder?</article-title>
<source/>Annu. Rev. Neurosci.
<volume>31</volume>, <fpage>247</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.30.051606.094313</pub-id><pub-id pub-id-type="pmid">18558855</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trevisiol</surname><given-names>A.</given-names></name><name><surname>Saab</surname><given-names>A. S.</given-names></name><name><surname>Winkler</surname><given-names>U.</given-names></name><name><surname>Marx</surname><given-names>G.</given-names></name><name><surname>Imamura</surname><given-names>H.</given-names></name><name><surname>Mobius</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Monitoring ATP dynamics in electrically active white matter tracts</article-title>. <source/>Elife
<volume>6</volume>:<fpage>24241</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.24241</pub-id><pub-id pub-id-type="pmid">28414271</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tricaud</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Myelinating schwann cell polarity and mechanically-driven myelin sheath elongation</article-title>. <source/>Front. Cell. Neurosci.
<volume>11</volume>:<fpage>414</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00414</pub-id><pub-id pub-id-type="pmid">29354031</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trigo</surname><given-names>D.</given-names></name><name><surname>Smith</surname><given-names>K. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Axonal morphological changes following impulse activity in mouse peripheral nerve <italic>in vivo</italic>: the return pathway for sodium ions</article-title>. <source/>J. Physiol. (Lond).
<volume>593</volume>, <fpage>987</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2014.279331</pub-id><pub-id pub-id-type="pmid">25524071</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukita</surname><given-names>S.</given-names></name><name><surname>Ishikawa</surname><given-names>H.</given-names></name></person-group> (<year>1980</year>). <article-title>The movement of membranous organelles in axons. Electron microscopic identification of antergradely and retrogradely transported organelles</article-title>. <source/>J. Cell Biol.
<volume>84</volume>, <fpage>513</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="pmid">6153657</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchida</surname><given-names>A.</given-names></name><name><surname>Colakoglu</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Monsma</surname><given-names>P. C.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Severing and end-to-end annealing of neurofilaments in neurons</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>110</volume>, <fpage>E2696</fpage>–<lpage>E2705</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1221835110</pub-id><pub-id pub-id-type="pmid">23821747</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uncini</surname><given-names>A.</given-names></name><name><surname>Gonzalez-Bravo</surname><given-names>D. C.</given-names></name><name><surname>Acosta-Ampudia</surname><given-names>Y. Y.</given-names></name><name><surname>Ojeda</surname><given-names>E. C.</given-names></name><name><surname>Rodriguez</surname><given-names>Y.</given-names></name><name><surname>Monsalve</surname><given-names>D. M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Clinical and nerve conduction features in Guillain-Barre syndrome associated with Zika virus infection in Cucuta, Colombia</article-title>. <source/>Eur. J. Neurol.
<volume>25</volume>, <fpage>644</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1111/ene.13552</pub-id><pub-id pub-id-type="pmid">29266602</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utzschneider</surname><given-names>D. A.</given-names></name><name><surname>Thio</surname><given-names>C.</given-names></name><name><surname>Sontheimer</surname><given-names>H.</given-names></name><name><surname>Ritchie</surname><given-names>J. M.</given-names></name><name><surname>Waxman</surname><given-names>S. G.</given-names></name><name><surname>Kocsis</surname><given-names>J. D.</given-names></name></person-group> (<year>1993</year>). <article-title>Action potential conduction and sodium channel content in the optic nerve of the myelin-deficient rat</article-title>. <source/>Proc. Biol. Sci.
<volume>254</volume>, <fpage>245</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1098/rspb.1993.0153</pub-id><pub-id pub-id-type="pmid">8108457</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Roermund</surname><given-names>C. W.</given-names></name><name><surname>Visser</surname><given-names>W. F.</given-names></name><name><surname>Ijlst</surname><given-names>L.</given-names></name><name><surname>van Cruchten</surname><given-names>A.</given-names></name><name><surname>Boek</surname><given-names>M.</given-names></name><name><surname>Kulik</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters</article-title>. <source/>FASEB J. <volume>22</volume>, <fpage>4201</fpage>–<lpage>4208</lpage>. <pub-id pub-id-type="doi">10.1096/fj.08-110866</pub-id><pub-id pub-id-type="pmid">18757502</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vander Heiden</surname><given-names>M. G.</given-names></name><name><surname>Cantley</surname><given-names>L. C.</given-names></name><name><surname>Thompson</surname><given-names>C. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Understanding the Warburg effect: the metabolic requirements of cell proliferation</article-title>. <source/>Science
<volume>324</volume>, <fpage>1029</fpage>–<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1126/science.1160809</pub-id><pub-id pub-id-type="pmid">19460998</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>M. E.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Why is Wallerian degeneration in the CNS so slow?</article-title>
<source/>Annu. Rev. Neurosci.
<volume>30</volume>, <fpage>153</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.30.051606.094354</pub-id><pub-id pub-id-type="pmid">17506644</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velumian</surname><given-names>A. A.</given-names></name><name><surname>Samoilova</surname><given-names>M.</given-names></name><name><surname>Fehlings</surname><given-names>M. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Visualization of cytoplasmic diffusion within living myelin sheaths of CNS white matter axons using microinjection of the fluorescent dye Lucifer Yellow</article-title>. <source/>Neuroimage
<volume>56</volume>, <fpage>27</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.11.022</pub-id><pub-id pub-id-type="pmid">21073961</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkenhoff</surname><given-names>A.</given-names></name><name><surname>Weiler</surname><given-names>A.</given-names></name><name><surname>Letzel</surname><given-names>M.</given-names></name><name><surname>Stehling</surname><given-names>M.</given-names></name><name><surname>Klambt</surname><given-names>C.</given-names></name><name><surname>Schirmeier</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Glial glycolysis is essential for neuronal survival in Drosophila</article-title>. <source/>Cell Metab.
<volume>22</volume>, <fpage>437</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.006</pub-id><pub-id pub-id-type="pmid">26235423</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voyvodic</surname><given-names>J. T.</given-names></name></person-group> (<year>1989</year>). <article-title>Target size regulates calibre and myelination of sympathetic axons</article-title>. <source/>Nature
<volume>342</volume>, <fpage>430</fpage>–<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1038/342430a0</pub-id><pub-id pub-id-type="pmid">2586612</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>P. R.</given-names></name><name><surname>Fields</surname><given-names>R. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Control of local protein synthesis and initial events in myelination by action potentials</article-title>. <source/>Science
<volume>333</volume>, <fpage>1647</fpage>–<lpage>1651</lpage>. <pub-id pub-id-type="doi">10.1126/science.1206998</pub-id><pub-id pub-id-type="pmid">21817014</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>L. J.</given-names></name><name><surname>Summers</surname><given-names>D. W.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Brace</surname><given-names>E. J.</given-names></name><name><surname>Milbrandt</surname><given-names>J.</given-names></name><name><surname>DiAntonio</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor</article-title>
<source/>NMNAT2. Elife
<volume>6</volume>:<fpage>22540</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.22540</pub-id><pub-id pub-id-type="pmid">28095293</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waller</surname><given-names>J.</given-names></name></person-group> (<year>1850</year>). <article-title>Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres</article-title>. <source/>Phil. Trans. R Soc. Lond.
<volume>140</volume>, <fpage>423</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1098/rstl.1850.0021</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Rapid movement of microtubules in axons</article-title>. <source/>Curr. Biol.
<volume>12</volume>, <fpage>1496</fpage>–<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-9822(02)01078-3</pub-id><pub-id pub-id-type="pmid">12225664</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Ho</surname><given-names>C. L.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Liem</surname><given-names>R. K.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Rapid movement of axonal neurofilaments interrupted by prolonged pauses</article-title>. <source/>Nat. Cell. Biol.
<volume>2</volume>, <fpage>137</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1038/35004008</pub-id><pub-id pub-id-type="pmid">10707083</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxman</surname><given-names>S. G.</given-names></name><name><surname>Craner</surname><given-names>M. J.</given-names></name><name><surname>Black</surname><given-names>J. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Na<sup>+</sup> channel expression along axons in multiple sclerosis and its models</article-title>. <source/>TiPS
<volume>25</volume>, <fpage>584</fpage>–<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2004.09.001</pub-id><pub-id pub-id-type="pmid">15491781</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wedel</surname><given-names>M. J.</given-names></name></person-group> (<year>2018</year>). <article-title>A monument of inefficiency: the presumed course of the recurrent laryngeal nerve in sauropod dinosaurs</article-title>. <source/>Acta Palaeontol. Polonica
<volume>57</volume>, <fpage>251</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.4202/app.2011.0019</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>H. B.</given-names></name><name><surname>Kuhlmann</surname><given-names>K.</given-names></name><name><surname>Shen</surname><given-names>S.</given-names></name><name><surname>Uecker</surname><given-names>M.</given-names></name><name><surname>Schardt</surname><given-names>A.</given-names></name><name><surname>Dimova</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Proteolipid protein is required for transport of sirtuin 2 into CNS Myelin</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>7717</fpage>–<lpage>7730</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1254-07.2007</pub-id><pub-id pub-id-type="pmid">17634366</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willison</surname><given-names>H. J.</given-names></name><name><surname>Jacobs</surname><given-names>B. C.</given-names></name><name><surname>van Doorn</surname><given-names>P. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Guillain-Barre syndrome</article-title>. <source/>Lancet
<volume>388</volume>, <fpage>717</fpage>–<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00339-1</pub-id><pub-id pub-id-type="pmid">26948435</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Williams</surname><given-names>J.</given-names></name><name><surname>Nathans</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Complete morphologies of basal forebrain cholinergic neurons in the mouse</article-title>. <source/>Elife
<volume>3</volume>:<fpage>e02444</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.02444</pub-id><pub-id pub-id-type="pmid">24894464</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Whiteus</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>C. S.</given-names></name><name><surname>Hayworth</surname><given-names>K. J.</given-names></name><name><surname>Weinberg</surname><given-names>R. J.</given-names></name><name><surname>Hess</surname><given-names>H. F.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Contacts between the endoplasmic reticulum and other membranes in neurons</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>114</volume>, <fpage>4859</fpage>–<lpage>4867</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1701078114</pub-id><pub-id pub-id-type="pmid">28559323</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyss</surname><given-names>M. T.</given-names></name><name><surname>Jolivet</surname><given-names>R.</given-names></name><name><surname>Buck</surname><given-names>A.</given-names></name><name><surname>Magistretti</surname><given-names>P. J.</given-names></name><name><surname>Weber</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>In vivo</italic> evidence for lactate as a neuronal energy source</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>7477</fpage>–<lpage>7485</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0415-11.2011</pub-id><pub-id pub-id-type="pmid">21593331</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Ohayon</surname><given-names>D.</given-names></name><name><surname>McKenzie</surname><given-names>I. A.</given-names></name><name><surname>Sinclair-Wilson</surname><given-names>A.</given-names></name><name><surname>Wright</surname><given-names>J. L.</given-names></name><name><surname>Fudge</surname><given-names>A. D.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>1210</fpage>–<lpage>1217</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4351</pub-id><pub-id pub-id-type="pmid">27455109</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yahata</surname><given-names>N.</given-names></name><name><surname>Yuasa</surname><given-names>S.</given-names></name><name><surname>Araki</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>6276</fpage>–<lpage>6284</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4304-08.2009</pub-id><pub-id pub-id-type="pmid">19439605</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Renier</surname><given-names>N.</given-names></name><name><surname>Simon</surname><given-names>D. J.</given-names></name><name><surname>Uryu</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>D. S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Pathological axonal death through a MAPK cascade that triggers a local energy deficit</article-title>. <source/>Cell
<volume>160</volume>, <fpage>161</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.053</pub-id><pub-id pub-id-type="pmid">25594179</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X. H.</given-names></name><name><surname>Crawford</surname><given-names>T. O.</given-names></name><name><surname>Griffin</surname><given-names>J. W.</given-names></name><name><surname>Tu</surname><given-names>P. H.</given-names></name><name><surname>Lee</surname><given-names>V. M.</given-names></name><name><surname>Li</surname><given-names>C. M.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>1953</fpage>–<lpage>1962</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-06-01953.1998</pub-id><pub-id pub-id-type="pmid">9482781</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>A.</given-names></name><name><surname>Rao</surname><given-names>M. V.</given-names></name><name><surname>Veeranna Nixon</surname><given-names>R. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Neurofilaments and Neurofilament Proteins in Health and Disease</article-title>. <source/>Cold Spring Harb. Perspect Biol.
<volume>9</volume>:<fpage>18309</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a018309</pub-id><pub-id pub-id-type="pmid">28373358</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zala</surname><given-names>D.</given-names></name><name><surname>Hinckelmann</surname><given-names>M. V.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Lyra da Cunha</surname><given-names>M. M.</given-names></name><name><surname>Liot</surname><given-names>G.</given-names></name><name><surname>Cordelieres</surname><given-names>F. P.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Vesicular glycolysis provides on-board energy for fast axonal transport</article-title>. <source/>Cell
<volume>152</volume>, <fpage>479</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.12.029</pub-id><pub-id pub-id-type="pmid">23374344</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalc</surname><given-names>B.</given-names></name><name><surname>Goujet</surname><given-names>D.</given-names></name><name><surname>Colman</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>The origin of the myelination program in vertebrates</article-title>. <source/>Curr. Biol.
<volume>18</volume>, <fpage>R511</fpage>–<lpage>R512</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2008.04.010</pub-id><pub-id pub-id-type="pmid">18579089</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zambonin</surname><given-names>J. L.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Ohno</surname><given-names>N.</given-names></name><name><surname>Campbell</surname><given-names>G. R.</given-names></name><name><surname>Engeham</surname><given-names>S.</given-names></name><name><surname>Ziabreva</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis</article-title>. <source/>Brain
<volume>134</volume>, <fpage>1901</fpage>–<lpage>1913</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awr110</pub-id><pub-id pub-id-type="pmid">21705418</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zawadzka</surname><given-names>M.</given-names></name><name><surname>Rivers</surname><given-names>L. E.</given-names></name><name><surname>Fancy</surname><given-names>S. P.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Tripathi</surname><given-names>R.</given-names></name><name><surname>Jamen</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination</article-title>. <source/>Cell Stem Cell
<volume>6</volume>, <fpage>578</fpage>–<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2010.04.002</pub-id><pub-id pub-id-type="pmid">20569695</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Watts</surname><given-names>R.</given-names></name><name><surname>Hoopfer</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration</article-title>. <source/>Neuron
<volume>39</volume>, <fpage>217</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00429-X</pub-id><pub-id pub-id-type="pmid">12873380</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Bekku</surname><given-names>Y.</given-names></name><name><surname>Dzhashiashvili</surname><given-names>Y.</given-names></name><name><surname>Armenti</surname><given-names>S.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Assembly and maintenance of nodes of ranvier rely on distinct sources of proteins and targeting mechanisms</article-title>. <source/>Neuron
<volume>73</volume>, <fpage>92</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.10.016</pub-id><pub-id pub-id-type="pmid">22243749</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>